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Resumo 
 
 
O código genético é geralmente visto como imutável, no entanto várias 
alterações à sua forma padrão são conhecidas. Uma das mais notáveis 
acontece em várias espécies do género Candida, onde o codão Leu-CUG  é 
descodificado como serina por um novo RNA transferência (Ser-tRNACAG). O 
laboratório de acolhimento fez um grande progresso ao reverter a alteração 
atípica do código genético do fungo patogénico humano C. albicans, usando 
uma combinação de tRNAs mutantes, recombinação genética e evolução 
forçada. Estes resultados levantaram a hipótese que as ambiguidades sintéticas 
do codão, combinadas com evolução experimental, poderem libertar os codões 
do seu estado fixo.  
Nesta tese testamos esta hipótese usando S. cerevisiae como modelo 
biológico. Geramos ambiguidade em codões específicos, de forma bifásica, 
envolvendo a deleção de genes de tRNA, seguida pela expressão de tRNAs 
não-cognatos capazes de compensar o tRNA eliminado. Tendo como base a 
ideia que os codões raros são mais suscetíveis a alterações que aqueles usados 
frequentemente, usamos duas estirpes knock-out, nas quais não existem os 
tRNAs cognatos capazes de descodificar os codões raros CUC-Leu e AGG-Arg.  
Exploramos então a vulnerabilidade destes codões pela construção de tRNAs 
mutantes que incorporam erradamente Ser nestes locais. Estas estirpes 
recombinantes foram evoluídas ao longo do tempo, usando evolução 
experimental. Apesar de ter havido um forte impacto negativo na taxa de 
crescimento de estirpes que expressam o tRNA mutante a altos níveis, esta 
expressão a baixos níveis teve pouco impacto no fitness celular. Descobrimos 
que não só a ambiguidade do codão, mas também destabilizações da pool de 
tRNAs endógenos têm um impacto negativo na taxa de crescimento. Após a 
evolução, as estirpes com elevada expressão do tRNA mutante recuperaram 
significativamente em vários parâmetros de crescimento, o que mostra que 
estas adaptam-se e exibem maior tolerância à ambiguidade do codão. Através 
do sistema repórter fluorescente desenvolvido monitorizamos a incorporação 
errónea de Ser, o que nos indica que a Ser está de facto a ser incorporada e 
que, possivelmente, a alteração da identidade do codão foi atingida.  
Apesar das consequências negativas gerais da ambiguidade do codão, 
demonstramos que os codões capazes de tolerar a perda do seu tRNA cognato, 
conseguem também tolerar a incorporação elevada de Ser. Isto levanta a 
hipótese que estes codões podem ser recodificados para outros aminoácidos 
naturais e/ou artificiais para a produção de proteínas com novas propriedades, 
contribuindo assim para o campo da Biologia Sintética e Biotecnologia. 
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Abstract 
 
Although the genetic code is generally viewed as immutable, alterations to its 
standard form occur in the three domains of life. A remarkable alteration to the 
standard genetic code occurs in many fungi of the Saccharomycotina CTG clade 
where the Leucine CUG codon has been reassigned to Serine by a novel transfer 
RNA (Ser-tRNACAG). The host laboratory made a major breakthrough by reversing 
this atypical genetic code alteration in the human pathogen Candida albicans 
using a combination of tRNA engineering, gene recombination and forced 
evolution. These results raised the hypothesis that synthetic codon ambiguities 
combined with experimental evolution may release codons from their frozen state.  
In this thesis we tested this hypothesis using S. cerevisiae as a model system. 
We generated ambiguity at specific codons in a two-step approach, involving 
deletion of tRNA genes followed by expression of non-cognate tRNAs that are 
able to compensate the deleted tRNA. Driven by the notion that rare codons are 
more susceptible to reassignment than those that are frequently used, we used 
two deletion strains where there is no cognate tRNA to decode the rare CUC-Leu 
codon and AGG-Arg codon.  
We exploited the vulnerability of the latter by engineering mutant tRNAs that 
misincorporate Ser at these sites. These recombinant strains were evolved over 
time using experimental evolution. Although there was a strong negative impact 
on the growth rate of strains expressing mutant tRNAs at high level, such 
expression at low level had little effect on cell fitness. We found that not only codon 
ambiguity, but also destabilization of the endogenous tRNA pool has a strong 
negative impact in growth rate. After evolution, strains expressing the mutant 
tRNA at high level recovered significantly in several growth parameters, showing 
that these strains adapt and exhibit higher tolerance to codon ambiguity. A 
fluorescent reporter system allowing the monitoring of Ser misincorporation 
showed that serine was indeed incorporated and possibly codon reassignment 
was achieved.  
Beside the overall negative consequences of codon ambiguity, we 
demonstrated that codons that tolerate the loss of their cognate tRNA can also 
tolerate high Ser misincorporation. This raises the hypothesis that these codons 
can be reassigned to standard and eventually to new amino acids for the 
production of proteins with novel properties, contributing to the field of synthetic 
biology and biotechnology.   
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Chapter 1 
1. Introduction 
 
1.1 Genetic code 
The genetic code was established 3.5 billion years ago (1) and is one of the oldest and most 
conserved characteristics of life. It is universally used across the three domains of life and can be 
defined as a series of biochemical reactions that establish the system of rules by which the 
information encoded by a nucleotide sequence is translated into a protein. Each three-nucleotide 
combination represents a codon which encodes a single amino acid. Since there are 4 nucleotides, 
there is a total of 64 combinations where 3 of them represent the termination codons UGA, UAA 
and UAG, and the remaining 61 encode for the 20 canonical amino acids (figure 1.1). This means 
that most amino acids are specified by more than one codon, showing the redundancy of the code. 
Codons that encode the same amino acid are named synonymous codons and are important to 
minimize the harmful effects of potential incorrectly placed nucleotides (2). However these 
synonymous codons are not equivalent and are used with different frequencies in high or low 
expressing genes, and in different organisms (3). This codon usage biases are linked with gene 
expression levels, translation efficiency and protein folding (4). (5) 
 
 
 
 
Figure 1.1 – Standard genetic code.  The genetic code is composed of 64 codons and each one is 
composed of 3 nucleotides. The initiation codon is highlighted as blue (AUG) and termination codons are 
highlighted as red (UAA, UAG, UGA), and the rest of the codons show their specified amino acid. Adapted 
from Clancy and Brown, 2008. 
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1.1.1 Reading the code 
Codon assignments are established by two major components: transfer RNAs (tRNA) and 
aminoacyl tRNA synthetases (aaRS). Codons are recognized by the complementary anticodon of its 
cognate tRNA, which in turn is aminoacylated by aaRS that are highly selective for the 
correspondent amino acid (6). This relationship is central to the genetic code and pivotal to protein 
biosynthesis (figure 1.2). 
 
 
 
1.1.1.1 Transfer RNAs 
Transfer RNAs are the interface between the genetic information encoded in messenger RNA 
(mRNA) and proteins. tRNAs are small molecules composed of a single polynucleotide chain with 
73-90 nucleotides which are arranged in a tridimensional L-shaped structure. Its secondary 
structure is often represented as a cloverleaf structure (figure 1.2a) composed by the acceptor 
stem, D arm, TψC arm, variable arm and the anticodon arm (7). The acceptor stem is composed of 
7 base pairs followed by an unpaired nucleotide at position 73 and the 3’-CCA terminal where the 
amino acid is attached, whereas the TψC and anticodon arms have a 5 base pair stem and a 7 
nucleotide loop. Stems are stabilized by Watson-Crick interactions and an occasional wobble G-U 
base pair is often observed. The major deviations seen in tRNA size are due to variations in 
nucleotide number in the variable and D loops. (8). One important structural motif is the anticodon 
Figure 1.2 – tRNA cloverleaf structure (a) and translation overview (b) highlighting the role of tRNAs in 
translation, and aminoacyl-tRNA synthetases (aaRS) in their aminoacylation. Adapted from Knight et al., 
2001 
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U-turn that involves the ubiquitous U33. This is responsible for an abrupt reversion in direction 
(~180°) of the tRNA chain which exposes the anticodon nucleotides to anticodon-codon pairing 
during posterior mRNA decoding (9). In turn, so that the tRNA is aminoacylated, aaRS must 
recognize the correct tRNA which involves a series of identity elements. 
Transfer RNAs have many post-transcriptional modifications and are by far the most and more 
diversely modified biological molecule. While some modifications simply involve the addition of a 
methyl group, others are rather complex and involve multi-step reactions catalyzed by a series of 
specialized enzymes. These ensure tRNA proper folding and function, and can be divided in two 
major groups:  those that affect structure, and those that tackle critical positions to mRNA decoding 
and aaRS recognition (10). Although modified nucleotides can be present all over the tRNA 
molecule, the two most frequent modifications are found in positions 34 and 37 present in the 
anticodon loop. For example, modifications in position 37 aid in the maintenance of the U-turn and 
influence frameshifting, and therefore have an impact in translational accuracy (11). Modifications 
in the wobble position 34 can account for some of the degeneracy of the genetic code; for example 
an U34 enables stacking with A and G nucleotides (the latter by wobble interaction), while a modified 
I34 (inosine-34) enables recognition of C, A and U nucleotides, thus altering tRNA decoding capacity 
(12). Generally, modifications in these two positions contribute to efficient anticodon-codon pairing 
and to stability of the tRNA-mRNA interaction during mRNA translation (11). Also, some modified 
nucleotides in the anticodon domain are crucial to aaRS’s ability to accurately aminoacylate tRNAs 
(13).  
Noteworthy, tRNAs have other parts on the biological theatre beyond its role as adaptor in 
protein synthesis, not only in its aminoacylated state but also in its uncharged form, and even in 
fragmented form (7). Uncharged tRNAs have been shown to act as molecular sensors of external 
stresses such as amino acid deprivation, which regulates global gene expression to counteract 
nutritional stress (14, 15). Beside the canonical function of aminoacyl-tRNAs, they have also been 
implicated in other non-ribosomal functions. In bacterial cell wall formation, they act as substrates 
for building peptidoglycan bridges (16); and also mediate aminoacylation of phospholipids in the 
bacterial cell membrane (17). They also have a role in antibiotic biogenesis and in protein labeling 
for degradation (7).  
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1.1.1.2 Aminoacyl-tRNA synthetases 
Aminoacyl-tRNA synthetases catalyze the aminoacylation reaction, which corresponds to the 
attachment of the correct amino acid to its cognate tRNA. This occurs through a two-step 
mechanism by first activating the amino acid and then transferring it to the tRNA. The aaRS binds 
and activates the amino acid with ATP, forming aminoacyl-adenylate (aa-AMP), and then this 
complex recognizes the cognate tRNA and transfers the amino acid to its 3’ end, releasing the AMP. 
This is a rather complex task for aaRS, as they have to recognize the correct tRNA (between a large 
family of structurally similar tRNAs), as well as discriminate amino acids (18). Despite this, aaRS 
have an overall error rate of 10-4 which is achieved by a series of quality control mechanisms (19). 
There is one aaRS for each one of the 20 amino acids, and their recognition is usually done in two 
phases: the first activating step is inaccurate and is followed by a second step where non-cognate 
amino acids are hydrolyzed by an intrinsic proofreading activity, namely editing. While some amino 
acids have quite distinct physical and chemical properties which facilitates their discrimination, 
some amino acids, such as valine and isoleucine, only differ by a methyl group and their 
discrimination cannot be accomplished without the aaRS editing activity (20). On the other hand, 
tRNA is a large molecule that allows a series of intricate contacts with aaRS during recognition, 
mainly with the discriminator base (N73), the acceptor stem, and the anticodon. These so called 
identity elements can be determinants or antideterminants whether they promote or prevent, 
respectively, the interaction between the aaRS and the tRNA. By so, aminoacyl tRNA synthetases 
establish the genetic code by accurately pairing cognate tRNAs with their corresponding amino 
acids (19).  
 
 
1.1.2 Protein biosynthesis 
After the transcription of a particular gene, the synthesis of its protein product can begin (figure 
1.3). Translation can generally be divided in three major steps: initiation, elongation and 
termination. This process is orchestrated by the ribosome, together with several auxiliary factors 
that bind to mRNA.  
Initiation begins with the loading of the initiator methionyl-tRNA (Met-tRNAi) in the ribosomal 
subunit 40S P site, forming a 43S pre-initiation complex. This is accomplished by eIF2·GTP complex, 
together with the eukaryotic translation initiation factors 1, 3 and 5 bound to the ribosomal subunit. 
With the help of eIF4F, the complex is positioned onto the 5′ end of a capped and polyadenylated 
mRNA and scans it until an initiator codon AUG is found, which in turn, is recognized by the Met-
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tRNAi. Assemblage of the ribosomal subunit 60S to the later complex is facilitated by eIF3, eIF1 and 
1A, forming the ribosome and enabling the elongation step. While Met-tRNAi is bounded to peptidyl 
(P) site, another aminoacylated tRNA is delivered by eEF1A·GTP to the acceptor (A) site of the 
ribosome. If the latter is the cognate tRNA, a peptide bond between the carried amino acid and the 
previous amino acid is formed. The deacylated tRNA is released and the complex is translocated, 
exposing the next codon to the A site and the process is repeated, codon by codon. When a 
termination codon is encountered, the eukaryotic release factor 1 (eRF1) binds to the A site, which 
triggers ribosome arrest and the finished peptide is released. With the aid of eRF3, the ribosomal 
subunits, along with deacylated tRNAs and auxiliary factors dissociate from mRNA, and are free to 
initiate another round of translation (21, 22).  
 
 
Figure 1.3 - mRNA translation. This process has three main phases: initiation (a), elongation (b) and 
termination (c), which requires a series of specific translation factors. Adapted from Walsh and Mohr, 
2011 
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1.2 Alternative genetic codes 
The genetic code is universally used by all forms of life and was initially postulated by Crick as a 
“frozen accident” unable to further evolve, since any alteration to the code would produce aberrant 
proteins, leading to proteome mayhem that would be lethal to the cell (2).  Nevertheless, several 
natural deviations from its standard form are known in various microorganisms and mitochondria 
(figure 1.4). Together with the expansion of the amino acid repertoire by incorporation of two 
natural non-canonical amino acids (23), it shows that the code is not as frozen as initially thought.  
 
 
 
The first natural alterations were discovered in human mitochondria and involved the decoding 
of the UGA stop codon as Trp, and the AUA-Ile codon as Met (24). Subsequent discoveries have 
shown that mitochondria are rather prone to codon identity reassignments and significant diversity 
of nonsense-to-sense and sense-to-sense reassignments is often found in Euglenozoans, 
Haptophytes, Stramenophiles, alveolates, green plants, red algae, fungi and metazoans (23). There 
are 16 known alterations in mitochondria and the rationalization is that they are particularly 
tolerant to reassignments due to their reduced genome size and complexity, when compared to 
nuclear genomes. Still, 10 alterations in nuclear codes were also found and termination codons are 
usually the only ones that are reassigned by the eukaryotic cytoplasmic translational machineries 
(24). For example, the UGA stop codon has been reassigned to Cys in Euplotes spp. (25) and to Trp 
in the Colpoda sp. and in various heterotrichs (26). The UUA and UAG stop codons have also been 
Figure 1.4 – Genetic code diversity found in mitochondria and in eubacteria, archaea and eukaryotic 
cytoplasm. Unchanged codons are in black. Adapted from Miranda et al., 2006 
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reassigned to Gln in diplomonads (27), ciliates (26) and green algae (28). Termination codons 
appear to be particularly flexible, as they are also the target for the incorporation of the non-
canonical amino acids selenocysteine, in a wide range of prokaryotes and eukaryotes (29) , and 
pyrrolysine in archaeal Methanosarcina species (30), producing novel classes of proteins with 
unique catalytic properties. The only known sense-to-sense reassignment in nuclear genomes is 
found in many fungi of the Saccharomycotina CTG with the decoding of the Leu-CUG codon as Ser 
(31, 32). Another interesting observation in nuclear genomes is that, in a small number of species, 
some codons like the Arg-AGA and Ile-AUA codons in Micrococcus spp., and the Arg-CGG 
codon is Mycoplasma capricolum are either extremely rare or absent, and appear 
unassigned (33). All together, these observations invalidate the hypothesis of a non-mutable 
code and shows that it is flexible and evolvable.  
 
 
1.2.1 Evolution of the genetic code 
Codon reassignments are an intriguing biological brainteaser since they show that the genetic 
code is still evolving, although these events are strongly selected against due to their intrinsic 
negative impact in proteome stability. Two evolutionary theories have arisen to explain how these 
alterations could emerge without leading to species extinction – the codon capture theory and the 
ambiguous intermediate theory (figure 1.5) (34).  
The codon capture theory (figure 1.5.a) was initially proposed by Osawa and Jukes as a neutral 
mechanism in which genetic code changes arise from fluctuations in the GC/AT balance in the 
evolving genome. It postulates that evolution of codon reassignment happens through a stage in 
which a particular codon disappears from the genome, possibly leading to the disappearance of the 
cognate tRNA. At a later time in evolution, the codon may reappear by genetic drift and be decoded 
through a non-cognate tRNA, misreading the codon and thus allowing its identity alteration (24, 
35). The disappearance of CGG-Arg codon from the AT-rich genome (75%) of Mycoplasma 
capricolum, rendered the hypothesis that an AT-rich genome has a genomic bias against GC 
content, which can drive GC-rich codons to disappear. This is further supported by the similar 
disappearance of AGA-Arg and AUA-Ile codons from the GC-rich genome (74%) of Micrococcus 
luteus (34). However, there are reassignments in genomes with no obvious GC or AT bias, and even 
cases where reassignments occurs against such bias, which questions the validity of this theory (36).  
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Alternatively, Schultz and Yarus proposed the ambiguous intermediate theory (figure 1.5.b) as a 
non-neutral mechanism driven through tRNA mutations (37). It postulates that codon 
reassignments can appear through an intermediate stage of codon ambiguity when a single codon 
is both decoded by its cognate tRNA and a mutant tRNA. This translational ambiguity is the initial 
step for a gradual codon reassignment, and if selected, will lead to a gradual decrease of the 
cognate tRNA usage, and eventually to its loss. (34, 37). This theory applies both to sense and 
nonsense codon reassignments, but in the latter case the termination codon is being disputed by 
the release factor (RF) and a mutant tRNA capable of decoding it (37). Since codon ambiguity leads 
to proteome wide amino acid misincorporation and consequently to the synthesis of aberrant 
proteins, it is expected to be strongly selected against, as it would be highly detrimental to cell 
survival. However, this theory is credited by the ambiguous decoding of the CUG-Leu codon as Ser 
in several extant Candida species (32) and by the dual meaning of the Bacillus subtilis UGA codon 
as Trp or stop (38). Contrary to codon capture theory, this does not impose codon disappearance 
but it states that rarely used codons are more prone to reassignment than frequently used ones, so 
the potential negative impact of codon ambiguities in the proteome is minimized (37). 
 
 
 
 
Figure 1.5 – Mechanisms of codon reassignments, where (a) illustrates the codon capture theory and 
(b) the ambiguous intermediate theory.  Adapted from Santos et al., 2004  
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1.2.2 Mechanisms of reassignment 
The molecular mechanisms of codon reassignment are poorly understood, however several 
studies provide interesting insight on how genetic code alterations may occur. They link them to 
alterations in components of the translational machinery accountable for interpreting the genetic 
code, namely tRNAs, aminoacyl-tRNA synthetases, and the release factors that recognize stop 
codons (39). As presented above (figure 1.4), some codons appear reassigned more frequently than 
others, particularly termination codons. Stop codon alterations are associated with critical 
structural changes in the codon recognition domain of release factors and in the anticodon of the 
misreading tRNAs. Such is the case of UAA and UAG decoding as Gln and UGA decoding as Trp or 
Cys, which occurs in several species of ciliates (39). It is proposed that this kind of reassignment 
happens through a first stage of codon ambiguity due to the appearance of a mutant tRNA capable 
of reading stop codon(s), and so competing with the RF. As ambiguity increases, the RF would fail 
in its ability to recognize the respective codon, enabling full reassignment (34). Another interesting 
way of exploiting the code was found by yeast mitochondria, where the four leucine CUN codons 
are decoded as threonine. This came as result of the loss of the Leu-tRNAUAG capable of decoding 
the CUN codons and the appearance of a mutant Thr-tRNAUAG with an atypically large anticodon 
loop. Surprisingly, this mutant Thr-tRNA has evolved from a His-tRNA, in which a single-nucleotide 
change converted it to a substrate for the yeast mitochondrial threonyl-tRNA synthetase (40). A 
distinct mechanism involves the reassignment of the nuclear Leu-CUG codon to Ser in various 
Candida species, where a mutation in the Ser-tRNACAG produced a novel tRNA that is recognized 
both by SerRS and LeuRS. This renders the CUG codon ambiguous, as it is decoded both as Ser and 
Leu in vivo (41). 
An important question raised by these studies is if, during the course of codon reassignment, 
tRNA selection can affect codon usage in a way that might lead to codon final reassignment. In this 
way, we have to consider two key aspects: tRNA abundance which is correlated with codon usage, 
and the strength of codon-anticodon interaction. Since codon reassignments tend to happen in less 
abundant codons, they are also translated by less abundant tRNAs (34) and such rarity renders 
them more vulnerable to competition during translation if a novel non-cognate tRNA would emerge 
(42). Strength of codon-anticodon interactions is modulated by tRNA structure and modified 
nucleosides, particularly those in the anticodon loop at positions N34, N37, and in some cases N35. 
Modified nucleosides in these positions have impact in codon recognition, and some have the 
potential to restrict the decoding capacity of tRNAs, while others expand it (39). For example, in 
squid mitochondria, Ser-tRNAGCU contains m7G34 which expands its capacity to read Arg-AGA and 
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AGG codons, inserting serine at these sites (43). The mitochondrial Asn-tRNA of echinoderms has a 
5’-Gψ35U-3’ anticodon which enables it to recognized AAA-Lys codons. Also, the decoding of 
mitochondrial AUA-Ile codons as methionine by Met-tRNACAU is enabled by t6A37 which stabilizes 
codon-anticodon interaction (34).  
 
 
1.2.3 Codon ambiguity and mistranslation 
Maintaining the integrity of the proteome is essential for cell viability as erroneous translation 
can induce protein misfolding and aggregation, and eventually cell death (figure 1.6). So codon 
ambiguities pose a striking problem to cellular homeostasis as they produce statistical proteins.  
 
 
 
High error rate in protein synthesis has been shown to cause disease phenotypes in mouse 
models where global mistranslation produce tissue-specific neurodegeneration (44, 45). For 
example, the sticky mutation was identified by Lee and coworkers in mice that exhibited 
progressive neurodegeneration and cerebellar Purkinje cell loss in the cerebellum. Due to a 
mutation in the editing domain of alanyl-tRNA synthetase, its proofreading activity was 
compromised which increased mischarching of non-cognate amino acids into Ala-tRNAs, 
Figure 1.6 – Delivery of aminoacylated tRNAs translational machinery. (A) Correctly aminoacylated 
tRNAs will lead to production of correctly folded WT proteins. (B) Misacylated tRNAs will produce errors 
that induce misfolding, which cause initiation of the unfolded protein response. Adapted from Lee et al., 
2006. 
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consequently leading to global mistranslation of codons decoded by these tRNAs, which led to 
accumulation of misfolded/unfolded proteins (44). Misfolded proteins are associated with multiple 
neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s diseases, and amino 
acid misincorporation may be a key trigger in the pathology of multiple sclerosis and amyotrophic 
lateral sclerosis (46, 47). Nevertheless, in natural conditions, the protein quality control machinery 
maintains a basal threshold of translational errors at a frequency of around 10-4 (46). Molecular 
chaperones are crucial to these mechanisms as they recognize misfolded proteins, which can either 
be refolded, degraded via the ubiquitin-proteasome pathway, or delivered to specialized 
compartments that sequester potentially toxic species (47). In the same way as the sticky mice, the 
woozy mutation was described with a similar phenotype of Purkinje cell loss (with exception of the 
cells in the most distal caudal lobule) as result of the accumulation of misfolded/unfolded proteins, 
due to a disruption in one of the chaperones of BiP, which is essential in misfolded protein 
translocation and folding, and ER stress sensing (45). 
Despite the inherent negative impact on proteome, ambiguous decoding of mRNA can create 
selective advantages in some circumstances. Reassignment of stop codons to selenocysteine (Sec) 
and pyrrolysine (Pyl) clearly proves this point. Selenium is an essential dietary micronutrient with 
antioxidant properties and its biological effects are delivered by selenium-containing proteins, the 
selenoproteins. These are present in all three domains of life but not in all species. Selenocysteine 
is the biological form of selenium in proteins, which is inserted at specific UGA codons by a complex 
selenosome machinery (39, 48). In eukaryotes, a unique Sec-tRNA is serylated by SerRS which is 
then converted to Sec. Selenocysteine is inserted in response to UGA stop codons in a very complex 
mechanism coordinated by an extraordinary number of factors (49). Also, in Euplotes crassus, 
specific UGA codons are decoded both as Sec and Cys and such ambiguity is necessary to produce 
fully functional proteins (50). On the other hand, in the methanogen family Methanosarcinaceae, 
UAG stop codons in specific genes are translated as pyrrolysine. This amino acid is incorporated in 
methylamine methyltransferases, rendering these methanogenic archaea their unique capability of 
methane synthesis using methylamines as precursors (51). This demonstrates that codon ambiguity 
is tolerable and indeed functional. 
It has been shown recently in HeLa cells grown under optimal conditions, that methionine 
misacylation corresponds to ~1.5% of all methionylated tRNAs, unveiling an unexpected basal level 
of mismethionylation in mammalian cells. Interestingly, upon viral infection the level of tRNA 
mismethionylation increased ~13%, and further increases were observed upon exposure to ROS-
inducing agents, and upon induction of the unfolded protein response. The authors found that the 
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trigger to this induction was oxidative stress (52), which is in concordance with the protective role 
conferred by Met residues in proteins against damage mediated by ROS, seen in E. coli (53). 
Noteworthy, mismethionylation has been proved to occur in mammalian (52), yeast (54) and 
bacterial cells (55). On the other hand, mistranslation induced by severe oxidative stress has been 
proved to be toxic in E. coli. Hydrogen peroxide is capable of oxidizing a critical cysteine residue in 
the editing domain of ThrRS, leading to serine misacylation of Thr-tRNAs, which induced protein 
mistranslation and reduced growth rate (56).  
In yeast, expression of the mutant Candida albicans Ser-tRNACAG induced highly detrimental 
ambiguity in the Leu-CUG codon and major decrease in fitness due to high level synthesis of 
aberrant proteins. These triggered the expression of a stress response that provided important 
selective advantages under stress conditions and allowed ambiguous cells to survive in otherwise 
lethal environments (e.g. toxic doses of heavy metals, salts and cycloheximide) (57). Recently, the 
first microorganism with an altered genetic code was engineered by reversion of the CUG identity 
in C. albicans from serine back to leucine. Surprisingly, these strains adapted to increasing Leu 
misincorporation, recovered growth rate to wild-type levels and displayed unexpected phenotypic 
variability, with highly variable colony and cell morphologies, and increased tolerance to antifungals 
(58). Altogether this indicates that genetic code alterations are not mere abnormalities and can, in 
fact, represent a potential to adaptation, allowing species to colonize new ecological niches. 
 
 
1.3 Saccharomyces cerevisiae as a biological model 
Yeast is a good biological model to study cellular processes conserved in Eukaryotes and its 
genome can be easily manipulated. It has a rapid growth and generation time, and is particularly 
easy to manipulate, replicate and maintain. S. cerevisiae cells are round and stable in haploid and 
diploid form. Their size depend on their state, strain and growth phase, and normally ranges from 
4 to 10 µm  (59).  
Yeasts genes are organized in 16 chromosomes and approximately 6,600 open reading frames 
(ORFs) have been annotated, with more than 80% functionally characterized (59, 60). In 1996, S. 
cerevisiae genome was the first sequenced eukaryotic genome (61). Due to conservation of 
homologous genes to human, yeasts are used as model systems for the study of human diseases. 
In fact, 60% of yeast genes have human homologues or at least one conserved domain with human 
genes (60). In addition, up to 30% of genes implicated in human diseases have a close yeast 
homologue (62).  
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There are a vast repertoire of well-established and widely used yeast cellular and molecular 
techniques, together with modern high-throughput tools (60). Particularly, DNA transformation 
techniques in yeast proved a powerful useful tool for genomics and proteomics studies as plasmids 
can be easily introduced in yeast cells either as replicating molecules or by genome integration (59, 
63). This proves yeast as a practical and resourceful model organism.  
Gene deletion techniques are also easily applicable. One example is the knock-out collection 
from Bloom-Ackermman and colleagues, used in this thesis, consisting of 204 nuclear encoded tRNA 
genes deletion, and even some double deletions. Their work exposed the highly complex 
architecture of the RNA pool, which revealed an extensive network of backup-compensation 
between and within tRNA families and, interestingly, that genes encoding identical tRNAs within 
the same family contribute differently to cell fitness. Also, deletions in single-copy and multi-copy 
tRNA families elicited different transcriptional responses. Of particular interest to this work, they 
identified two single-copy tRNA families, tL(GAG)G and tR(CCU)J, as non-essential upon deletion. 
This genetic perturbation resulted in a strong growth defect of the cells due to the inexistence of a 
cognate tRNA to decode the CUC-leucine codon and AGG-arginine codon (64), rendering them 
“orphan codons”. 
 
 
1.4 Working hypothesis and objectives 
The host laboratory has made a major breakthrough by engineering the first complete codon 
reassignment in the human pathogen Candida albicans, using a combination of tRNA engineering, 
gene recombination and forced evolution (58). This raised the hypothesis that synthetic codon 
ambiguities combined with experimental evolution have the power to re-code rare sense codons. 
In this project, we used the described above yeast tRNA gene deletion library, particularly the 
two strains with viable single-copy tRNA gene deletions to test the hypothesis that rare codons can 
be reassigned using experimental evolution. For this, we engineered a mutant serine tRNA (58) to 
misincorporate Ser at CUC-leucine and AGG-arginine sites on a proteome wide scale, and evolved 
the ambiguous strains using experimental evolution. The specific objectives of this Masters Thesis 
are the following: 
1 – Construction of Saccharomyces cerevisiae strains with ambiguity in rare Leu and Arg codons; 
2 – Experimental evolution of ambiguous strains to reassign sense codons; 
3 – Development of a reporter system to monitor Ser misincorporation at CUC-leucine and AGG-
arginine sites.  
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Chapter 2 
2. Materials and Methods 
 
2.1 Strains and growth conditions 
2.1.1 Strains 
Escherichia coli strain JM109 (recA1 SupE44 endA1 hsdR17 gyrA96 relA1 thi Δ[Lac-proAB] 
F’[traD36 proAB-lacI lacZΔM15) was used as a host for all DNA manipulations.  
Saccharomyces cerevisiae strains used in this thesis are haploid and based on the genetic 
background of Y5565 (table 2.1). ΔtL(GAG)G and ΔtR(CCU)J are knock-out strains that have a 
deletion of the single-copy genes tL(GAG)G and tR(CCU)J that encode tRNALeuGAG and tRNAArgCCU, 
respectively. These strains belong to a tRNA gene deletion library that was kindly provided by Dr. 
Yitzhak Pilpel (64). 
 
 
Strain Genotype 
Y5565 
MATα, can1Δ::MFA1pr-HIS3, mfα1Δ::MFα1pr-LEU2, lyp1Δ, ura3Δ0, 
leu2Δ0, his3Δ1, met15Δ0 
ΔtL(GAG)G 
ΔtL(GAG)G::Hyg, MATα, can1Δ::MFA1pr-HIS3, mfα1Δ::MFα1pr-LEU2, 
lyp1Δ, ura3Δ0, leu2Δ0, his3Δ1, met15Δ0 
ΔtR(CCU)J 
ΔtR(CCU)J::Hyg, MATα, can1Δ::MFA1pr-HIS3, mfα1Δ::MFα1pr-LEU2, 
lyp1Δ, ura3Δ0, leu2Δ0, his3Δ1, met15Δ0 
 
 
2.1.2 Growth conditions 
E. coli cells were grown at 37 ºC in LB broth medium or LB with 2% agar (Formedium) 
supplemented with ampicillin (75 µg/ml; Sigma-Aldrich). 
Saccharomyces cerevisiae cells were grown at 30ºC in YPD (2% glucose). Transformed S. 
cerevisiae cells were grown in minimal medium lacking uracil (MM-Ura; 0,67% yeast nitrogen base 
without amino acids, 2% glucose, 2% agar and 100 µg/ml required amino acids – drop-out mixture 
in annexes).  
After evolution experiments, yeast cells were grown in 5-fluoro-orotic acid (5-FOA) plates 
(description in annexes). The purpose of this assay was to select cells that lost the plasmid 
containing the URA3 marker, so that transformation of the same cells with another plasmid (with 
Table 2.1 – Yeast strains used in this study 
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the same marker) was possible. For this, 100 µl of an evolved clone from each strain were plated in 
5-FOA plates and left at 30ºC for 2 days, until colonies were visible. 
 
 
2.2 Oligonucleotides 
Oligonucleotides (table 2.2) were purchased from IDT – Integrated DNA Technologies and 
ressuspended in miliQ water to a final concentration of 100 mM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oligo Sequence (5’ -> 3’) Tm (ºC) 
oUA2133 CGCGTCGACGTCCAGGACTGATTTATGTGCATC 60 
oUA2134 CGCGGATCCCAGTATGGATTGCTAGTCCTAGAG 60 
oUArg1 CGCACTAGTCAGTATGGATTGCTAGTCCTAGAG 61.5 
oUArg2 GGTTAAGGAGAAAGACTACGAATCTTTTGGGCTTTGC 62.7 
oUArg3 GCAAAGCCCAAAAGATTCGTAGTCTTTCTCCTTAACC 62.7 
oUArg4 GGTTAAGGAGAAAGACTTAAAATCTTTTGGGCTTTGC 60.9 
oUArg5 GCAAAGCCCAAAAGATTTTAAGTCTTTCTCCTTAACC 60.9 
oUArg6 AAGGCGATTAAGTTGGGTA 51.1 
oUArg7 ACACAGGAAACAGCTATGA 51 
oUArg10 GGTTAAGGAGAAAGACTGAGAATCTTTTGGGCTTTGC 62.8 
oUArg11 GCAAAGCCCAAAAGATTCTCAGTCTTTCTCCTTAACC 62.8 
oUArg14 CGCACTAGTGTCCAGGACTGATTTATGTGCATC 62.9 
oUArg15 CGCGCGGCCGCCAGTATGGATTGCTAGTCCTAGAG 69.9 
oUArg16 TATGGTACCCTAGCTTATTTGTACAATTCATC 56.5 
oUArg17 TATCTCGAGCTCGAGGAGCTATTAAGATC 58.4 
oUArg18 GTTACCAGACAACCATTACCUCTCCACTCAATCTGCCTTAT 64.4 
oUArg19 ATAAGGCAGATTGAGTGGAGAGGTAATGGTTGTCTGGTAAC 64.4 
oUArg20 GTTACCAGACAACCATTACTCTTCCACTCAATCTGCCTTAT 63.5 
oUArg21 ATAAGGCAGATTGAGTGGAGAGGTAATGGTTGTCTGGTAAC 64.4 
oUArg22 AGAAGGTTATGTTCAAGAAAGGACTATTTTTTTCAAAGATG 59.2 
oUArg23 CATCTTTGAAAAAAATAGTCCTTTCTTGAACATAACCTTCT 59.2 
oUArg24 AGAAGGTTATGTTCAAGAATCTACTATTTTTTTCAAAGATG 57.9 
oUArg25 CATCTTTGAAAAAAATAGTAGATTCTTGAACATAACCTTCT 57.9 
oUArg26 TATGGATGAATTGTACAAA 43.4 
oUArg27 CATTCTTTTGTTTGTCAGCC 50.2 
oUArg28 GTATTCCAATTTGTGACC 45.6 
oUArg29 GGTAAATTGCCAGTTCCATG 51.9 
oUArg30 TGTGTGGAATTGTGAGCGGA 56.9 
Table 2.2 – List of oligonucleotides used in this thesis  
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2.3 Plasmids 
2.3.1 Original plasmids    
In this work we used the following plasmids (table 2.3) as backbone for the new constructions 
(section 2.3.2): 
 
 
Plasmid Description 
pUA261 
Plasmid based on pRS315 with a single copy of the C. albicans tRNASerUGA gene 
inserted between SalI e BamHI cloning sites  
pRS426 
Multi-copy plasmid with 5726 bp containing the AmpR and URA3 gene, allowing 
for selection of transformed cells in LB media with ampicillin or minimal media 
lacking uracil, respectively 
pRS316 
Single-copy plasmid with 4887 bp belonging to a series of pBluescript-based 
centromere vectors. Contains the AmpR and URA3 gene 
pACT1-GFP 
Plasmid based on CIP10 containing the codon-optimized yeast enhanced GFP 
(yEGFP) gene (65)  
 
 
 
2.3.2 Constructed plasmids 
For expression of the chimeric C. albicans tRNASerUGA gene in S. cerevisiae, we used the plasmid 
pUA261 to amplify the tRNASerUGA gene with the primers oUA2133 and oUA2134. The gene was then 
cloned into SalI e BamHI restriction sites of pRS426 and pRS316, originating the plasmids pUA715 
and pUA716, respectively (figure 2.1 in annexs).   
The anticodon of the tRNASerUGA gene, inserted in pUA715 and pUA716, was altered by site-
directed mutagenesis to CCU and GAG in order to generate mutant misreading tRNA genes. 
Expression of tRNASerCCU from multi and single-copy plasmids (pUA717 and pUA718) promotes the 
insertion of serine at AGG arginine sites in strains lacking the tRNA that recognizes this codon 
(ΔtR(CCU)J). Expression of tRNASerGAG from multi and single-copy plasmids (pUA719 and pUA720) 
promotes the insertion of serine at CUC leucine sites in strains lacking the tRNA that recognizes this 
codon (ΔtL(GAG)G). 
In order to monitor Ser misincorporation, we developed a loss-of-function reporter system 
based on the codon-optimized yeast enhanced GFP (yEGFP) gene and assembled it on the multi-
copy plasmids pRS426, pUA715, pUA717 and pUA719, in different versions. For that, first we 
amplified the yEGFP gene plus the promoter ACT1 from pACT1-GFP, using the primers oUArg16 and 
oUArg17, and then inserted it between the KpnI e XhoI cloning sites of the referred plasmids. This 
Table 2.3 – Original plasmids used in this study 
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originated the plasmids pUA721 (figure 2.2 in annexes), pUA728, pUA733 and pUA736, 
respectively.  
To monitor misincorporation of serine at leucine sites, we used a strategy previously optimized 
in the host laboratory for C. albicans (58) on the plasmids pUA721, pUA728 and pUA733. We 
changed the leucine codon UUA in position 201 (L201) of the yEGFP by site-directed mutagenesis 
to leucine codon CUC, yielding plasmids pUA725, pUA730 and pUA735. In this way, when Ser is 
incorporated at residue 201, it causes a destabilization in GFP rendering it inactive, permitting the 
monitorization of Ser misincorporation by tRNASerGAG. Next, in order to have a negative control, we 
altered this same codon to the serine UCU codon, originating plasmids pUA723, pUA729 and 
pUA734.  
Lastly, to monitor misincorporation of serine at AGG arginine sites, we used an analogous 
strategy on the plasmids pUA721, pUA728 and pUA736. For that, we changed the codon AGA in 
position 96 (correspondent to arginine, R96) by site-directed mutagenesis to codon AGG, yielding 
the plasmids pUA727, pUA732 and pUA738. Like in the last case, when Ser is incorporated at this 
residue renders GFP inactive, allowing the monotorization of Ser misincorporation by tRNASerCCU. 
Next we produced the negative control altering the codon of this residue to UCU, originating 
plasmids pUA726, pUA731 and pUA737. 
 
Plasmids Description 
pUA715 Multi-copy plasmid with insertion of Ser-tRNAUGA gene between SalI e BamHI 
pUA716 Single-copy plasmid with insertion of Ser-tRNAUGA gene between SalI e BamHI 
pUA717 
Plasmid based on pUA715, constructed by site directed mutagenesis of the 
anticodon of the Ser-tRNAUGA gene to CCU 
pUA718 
Plasmid based on pUA716, constructed by site directed mutagenesis of the 
anticodon of the Ser-tRNAUGA gene to CCU 
pUA719 
Plasmid based on pUA715, constructed by site directed mutagenesis of the 
anticodon of the Ser-tRNAUGA gene to GAG 
pUA720 
Plasmid based on pUA716, constructed by site directed mutagenesis of the 
anticodon of the Ser-tRNAUGA gene to GAG 
pUA721 
Plasmid pRS426 with insertion of ACT1-GFP between the restriction sites of 
KpnI and XhoI 
pUA723 
Plasmid based on pUA721, constructed by site directed mutagenesis of the 
codon correspondent to L201 to TCT 
pUA725 
Plasmid based on pUA721, constructed by site directed mutagenesis of the 
codon correspondent to L201 to CUC 
Table 2.4 – List of the engineered plasmids 
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pUA726 
Plasmid based on pUA721, constructed by site directed mutagenesis of the 
codon correspondent to R96 to TCT 
pUA727 
Plasmid based on pUA721, constructed by site directed mutagenesis of the 
codon correspondent to R96 to AGG 
pUA728 
Plasmid based on pUA715 with insertion of ACT1-GFP between the restriction 
sites of KpnI and XhoI  
pUA729 
Plasmid based on pUA729, constructed by site directed mutagenesis of the 
codon correspondent to L201 to TCT 
pUA730 
Plasmid based on pUA729, constructed by site directed mutagenesis of the 
codon correspondent to L201 to CUC 
pUA731 
Plasmid based on pUA729, constructed by site directed mutagenesis of the 
codon correspondent to R96 to TCT 
pUA732 
Plasmid based on pUA729, constructed by site directed mutagenesis of the 
codon correspondent to R96 to AGG 
pUA733 
Plasmid based on pUA719 with insertion of ACT1-GFP between the restriction 
sites of KpnI and XhoI 
pUA734 
Plasmid based on pUA733, constructed by site directed mutagenesis of the 
codon correspondent to L201 to TCT 
pUA735 
Plasmid based on pUA733, constructed by site directed mutagenesis of the 
codon correspondent to L201 to CUC 
pUA736 
Plasmid based on pUA717 with insertion of ACT1-GFP between the restriction 
sites of KpnI and XhoI 
pUA737 
Plasmid based on pUA736, constructed by site directed mutagenesis of the 
codon correspondent to R96 to TCT 
pUA738 
Plasmid based on pUA736, constructed by site directed mutagenesis of the 
codon correspondent to R96 to AGG 
 
 
 
2.3.3 Site directed mutagenesis 
This procedure was used with the goal of mutating the anticodon of C. albicans tRNASerUGA gene 
and the codons of leucine and arginine residues (L201 and R96, respectively) of yEGFP gene. For 
that, polymerase chain reactions (PCR) were prepared with 1x Pfu Buffer with MgSO4, 0.2 mM 
dNTPs, 0.2 mM of each respective primer, 1.25 U of Pfu polymerase, 5-25 ng of plasmidic DNA, and 
miliQ water to a final volume of 25 µl. The PCR program used consisted of a cycle of 30 seconds at 
95 ºC, 1 minute at 55 ºC and 7 minutes at 68ºC. Finally, the resulting products were treated with 
0.5 µl of DpnI for 2 hours, at 37 ºC. The goal was to digest the parental DNA template and select for 
the mutation-containing DNA. After digestion, plasmids were transformed in E. coli competent cells 
and plasmid DNA was extracted for DNA sequencing (StabVida sequencing services). 
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2.4 Preparation of E. coli competent cells 
E. coli competent cells were prepared from strain JM109 using the TFB method (66) . First, 200 
µl of an overnight culture was inoculated in 5 ml of LB medium and left in the incubator at 37 ºC, 
180 rpm, until they reached an OD600 of 0.3. Then, 4 ml of the late culture were inoculated in 100 
ml of LB medium and left to grow in the same conditions until they reached an OD600 of 0.3. After 
this, cells were collected in two falcons, cooled on ice for 5 minutes and centrifuged at 2500 rpm 
for 5 minutes, at 4 ºC. The supernatant was discarded and the pellet ressuspended in 20 ml of cold 
TFBI (0.03 mM potassium acetate, 0.08 mM RbCl2, 0.013 mM CaCl2, 0.08 mM MnCl2, 15.4% glycerol, 
pH 5.8). Cell suspension was centrifuged at 2500 rpm for 5 minutes, at 4 ºC and after rejection of 
the supernatant, the pellet was ressuspended in 2.5 ml of cold TFBII (0.01 mM MOPS Ca, 0.01 mM 
CaCl2, 0.008 mM RbCl2, 13.4% glycerol, pH 6.5). Cells were then incubated on ice for 5 minutes and 
distributed on aliquots of 200 µl each and stored at -80 ºC.  
 
 
2.5 Plasmidic DNA purification from E. coli 
2.5.1 Miniprep Kit 
For the extraction and purification of plasmidic DNA, we used GeneJETTM Plasmid Miniprep kit 
(Fermentas). Recombinant E. coli cells were inoculated in 5 ml or 10 ml of LB medium with 75 µg/ml 
ampicillin in the case of multi-copy or single-copy plasmids, respectively, and grown overnight at 
37 ºC. Cells were harvested at 8000 rpm for 2 minutes, the supernatant was removed and the 
procedure was followed according to the manufacturer instructions. After the purification, DNA 
concentration was quantified using the NanoDrop system and plasmids were stored at -20 ºC. 
 
 
2.5.2 “Homemade minipreps” 
For screening procedures, a cheap miniprep protocol that avoided the use of the kit columns 
was established. Briefly, 1.5 ml of E. coli cultures grown overnight were collected by two rounds of 
centrifugation at 13000 rpm, ressuspended in 1 ml of cold solution I (0.5 mM glucose, 250 mM Tris, 
10 mM EDTA) and incubated on ice for 5 minutes. Then, it was added 200 µl of solution II (0.2 M 
NaOH, 1% SDS), at room temperature, and incubated again on ice for 5 minutes. This was followed 
by the addition of 150 µl of cold solution III (1 mM KOAc saturated with KOH) and by other 
incubation on ice. The suspension was then centrifuged at 13000 rpm for 10 min and supernatant 
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was collected. After a series of precipitations with isopropanol and ethanol 70%, the pellet was 
dried, ressuspended in water and quantified using NanoDrop. 
 
 
2.6 Plasmidic DNA purification from S. cerevisiae 
For the extraction and purification of plasmidic DNA from yeast, we used Wizard® Genomic 
DNA Purification Kit from Promega, and followed the instructions from the manufacture. 
 
 
2.7  Transformation procedures 
2.7.1 Escherichia coli  
Transformation of E. coli cells was performed using the chemical SOC method (66). For this, 10 
ng of plasmidic DNA was added to thawed aliquots of competent cells (JM109), mixed and 
incubated on ice for 30 minutes. This was followed by a heat-shock at 42 ºC for 90 seconds and 
then cooled on ice for 2 minutes. Next, 800 µl of SOC (for preparation of 100 ml at pH 7, 2 g of 
tryptone, 0.5 g of yeast extract and 0.05 g of NaCl were weighted, and 1 ml of KCl 250 mM and 20 
ml of glucose 1M were added) were added to the transformation mix and then incubated at 37 ºC, 
180 rpm for 1 hour. After this, cell suspension was centrifuged at 2500 rpm for 1 minute and the 
supernatant was removed, leaving approximately 50 µl that were homogenized and plated in solid 
LB supplemented with 75 µg/ml of ampicillin. Plates were incubated at 37 ºC, overnight. 
 
 
2.7.2 Saccharomyces cerevisiae 
Yeast transformation was accomplished using the lithium acetate (LiAc) method described by 
Gietz and Woods (63). Briefly, 1.5 ml of overnight cultures were harvested in log phase by 
centrifugation for 1 minutes at 4000 rpm. The supernatant was discarded and the following 
reagents were added to the pellet in sequence: 240 µL of PEG 50% (w/v), 36 µL of LiAc 1 M, 25 µL 
of previously denatured single-stranded salmon sperm carrier DNA (2 mg/mL) and 36 µl dH2O plus 
0.1-1 µg of plasmid DNA. The mixture was ressuspended and submitted to a heat-shock treatment 
at 42 ºC for 1 hour. Cells were harvested by centrifugation for 1 minute at 13000 rpm, the 
supernatant was removed and the pellet resuspended in minimal medium lacking uracil. The cell 
suspension was then plated in solid MM-Ura medium and incubated for 3 to 5 days at 30 ºC, until 
colonies were visible. 
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2.7.3 Saccharomyces cerevisiae (alternative) 
When the LiAc method proved unfruitful, we used an adapted and modified transformation 
protocol for Candida albicans (67). In this version, 5 ml of overnight cultures were harvested in log 
phase by centrifugation for 5 minutes at 4000 rpm and the pellet was ressuspended in 150 µl LiAc-
sol (10% LiAc 1M, pH 7.5; 10% TE 10x, pH 7.5). 5 µg of plasmid DNA was added to the suspension, 
followed by 100 µg of single-stranded DNA carrier and 600 µl of PEG/LiAc-sol. (50% PEG 50% (w/v), 
50% LiAc-sol), and mixed. The transformation mix was incubated overnight at 30ºC, 180 rpm and 
submitted to a heat-shock at 44 ºC during 15 minutes and then cooled on ice about 2 minutes. The 
cell suspension was centrifuged in a bench top centrifuge at maximum speed for 1 minute and the 
supernatant was discarded. The pellet was ressuspended in 150 µl of MM-Ura and platted in solid 
MM-Ura medium and incubated for 3 to 5 days at 30 ºC, until colonies were visible. 
 
 
2.8 Colony PCR 
Colony PCR was used to check for the correct transformation of E. coli and yeast cells. For this, 
individual colonies from selective plates were picked using a P10 tip and were homogenized in 5 µl 
of miliQ water. Cell suspension was submitted to a heat shock at 95 ºC for 5 min. Next, PCR reagents 
were added to each tube: 1x DreamTaq Buffer, 0.2 mM dNTP mix, 0.15 mM of each primer, 1.25 U 
of DreamTaq polymerase and miliQ water to a final volume of 15 µl. General PCR programs 
consisted an initial denaturation at 95 ºC for 3 minutes, followed by 30 cycles of a denaturation 
step at 95 ºC for 30 seconds, a annealing step for 30 seconds at variable temperature and an 
extension step at 72 ºC for 1 minute. Reactions were performed in a MyCyclerTM thermal cycler 
(BIORAD) and ended with a final extension step at 72 ºC for 5 minutes. The PCR products were 
subjected to a gel electrophoresis for quality check.  
 
 
2.9 Growth curves and rates 
Growth curves were established for all strains in minimal medium lacking uracil or YPD in the 
case of non-transformed cells. First, cultures were pre-incubated for 3 days in the appropriate 
medium at 30ºC with constant shaking at 180 rpm. The optical density (OD) of the pre-inoculum 
was measured at 600 nm and then the cultures were inoculated in fresh media to an initial OD600 
of 0.01. After approximately 7 hours, the OD was monitored each hour until they reached stationary 
phase. Data obtained was plotted in a graph as log(OD600) as a function of time (h). A trend line was 
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a fitted to the exponential phase of growth and its slope represented the growth rate of the clones. 
This procedure was carried out with five different clones from each strain, in the non-evolved and 
evolved state.  
 
 
2.10  Evolution experiments 
Experimental evolution assays were carried out using 5 clones of each newly constructed strain, 
as well as wild-type and knock-out control strains. Control cells were grown in 1 ml of YPD, whereas 
transformed cells were grown in 1 ml of minimal medium lacking uracil at 30ºC, until they reached 
stationary phase. Then cells were diluted by a factor of 1:200 into fresh medium (number of 
generations). This procedure was repeated until the strains reached approximately 200 
generations. Number of generations was calculated as shown in the equation below. 
 
 
 
 
2.11  Northern Blot Analysis 
2.11.1 Total RNA extraction  
For total RNA extractions, 50 ml cultures of S. cerevisiae cells were grown overnight in minimal 
medium and harvested at an OD600 of 1-1.5. The pellets were then frozen overnight at -80ºC. 
Frozen cells were resuspended in hot acid-phenol:chloroform 5:1 (pH 4.7) and TES-buffer (10 
mM Tris pH 7.5, 10 mM EDTA, 0.5% SDS) and incubated for 1 hour, at 65ºC, with repeated shaking 
every 10 minutes. Cell suspension was centrifuged at 13000 rpm for 20 minutes, at 4ºC. Then the 
RNA containing aqueous phase was transferred to new tubes and the same volume of acid-
phenol:chloroform 5:1 (pH 4.7) was added. The suspension was mixed using a vortex and 
centrifuged at 13000 rpm for 10 minutes, at 4ºC and this step was repeated. The aqueous phase 
was transferred to a new tube with the same volume of chloroform:isoamil-alchool 24:1, vortexed 
hard and centrifuged at 13000 rpm for 10 minutes, at 4ºC. Then 350 µl of the aqueous phase was 
transferred to a new tube containing 35 µl of sodium acetate (3 mM NaAc, pH 5.2) and 800 µl of 
ethanol 100% (-20ºC). The aqueous phase was precipitated overnight at -20ºC. Tubes were then 
centrifuged at 13000 rpm for 5 minutes, at 4ºC. The fluid was carefully removed without touching 
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the RNA-pellet and the later was washed with 500 µl of ethanol 80% (-20ºC) and briefly spinned 
down at 13000 rpm. The ethanol was removed and the tubes were air-dried so that all traces of 
ethanol were removed. The pellet was dissolved in 100 µl of sterile miliQ water and the 
concentration was quantified by Nanodrop. 
 
 
2.11.2 Northern blot 
Fractionation of total tRNAs was carried out on 12-15% polyacrylamide (40% Acril:Bis) gels 
containing 8 M urea (0.8 mm thick, 30 cm long). In each gel slot, 50 µg of total RNA sample was 
loaded and gels were electrophoresed at 500 V for 16 hours. Fractioned tRNAs were localized by 
UV shadowing, the portion of the gel containing tRNAs was cut and transferred onto a nitrocellulose 
membrane (Hybond N, Amersham) using a Semy-dry Trans Blot (Bio-Rad). For hybridization, probes 
were prepared using 10 pmol of dephosphorylated oligonucleotide and 4 µl of ɤ-32P-ATP 
(5000Ci/mmol) (Perkin Elmer) in 1x T4 kinase buffer, 10 mM spermidine and 16 units of T4 kinase 
(Takara). Labelling reaction was incubated at 37ºC for 1 hour and then the probe was extracted 
using phenol:chloroform:isoamyl alcohol (PCIA). The hybridization protocol was performed as 
described by Jacques Heitzler (68). Membranes were pre-hybridized for 30 minutes at 53 ºC in a 
hybridization solution [5x Denhardt’s solution (1% Ficol, 1% Polyvinylpyrrolidone and 1% Bovine 
serum albumin), 6x SSPE (3 M NaCl, 173 mM NaH2PO4, 25 mM EDTA) and 0.05% SDS]. Membrane 
hybridization was performed overnight in the above buffer using probes oUA2199 for detection of 
WT and mutant Ser-tRNA and oUA2195 for detection of the WT control Gly-tRNACCC (table 2.5). 
Membranes were then washed 4 times (3 minutes each time) in 2x SSPE, 0.5% SDS at 53 ºC. The 
membranes were exposed overnight with intensifying screens and developed using a Molecular 
Imager FX (Biorad). 
 
Probe Detection Tm (ºC) Sequence (5’ -> 3’) 
oUA2199 WT and mutant Ser-tRNAUGA 51,5 TTAACCGCTCGGACAAGTT 
oUA2195 WT Gly-tRNACCC 52-55 GCGGAAGCCGGGAATCGAAC 
 
 
 
 
Table 2.5 – List of oligonucleotides used for northern blot analysis 
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2.12    Epifluorescence microscopy 
To monitor Ser misincorporation, yEGFP expression was visualized in S. cerevisiae cells by 
epifluorescence microscopy. Strains were grown overnight in liquid media at mid-exponential 
phase and aliquots were spotted onto microscope slides. Fluorescence was detected using a Zeiss 
MC80 Axioplan 2 light microscope, equipped for epifuorescence microscopy with filter set HE38. 
Photographs were taken using an AxioCam HRc camera and images were analysed using ImageJ 
software. Mean fluorescence intensities (± standard deviation) were quantified in individual 
Leucine mutant cells expressing the reporter yEGFP Leu-UUA201 (positive control), Ser-UCU201 
(negative control) and Ser/Leu-GAG201 (reporter). In Arginine mutants, intensities were quantified 
in individual cells expressing the reporter yEGFP Arg-AGA96 (positive control), Ser-UCU96 (negative 
control) and Ser/Leu-AGG96 (reporter). yEGFP fluorescence (intensity/pixel) was determined for at 
least 1000 cells in each case. 
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Chapter 3 
 
3. Characterization of codon ambiguities 
 
3.1 Overview 
Despite the highly detrimental proteome chaos that genetic code alterations create, they are 
known to occur across the three domains of life which invalidate the hypothesis of a non-mutable 
code. This raises the intriguing question of how can cells cope with changes in the meaning of the 
code, since 10 to 50% of amino acid substitutions have the potential to disrupt protein function 
(69), by synthesis of aberrant, misfolded or non-functional proteins. However, genetic code 
ambiguity is also a source of protein innovation and phenotypic diversity (29, 30, 48, 58, 70). 
Generation of new proteins with novel functions for biotechnological, pharmaceutical, green 
chemistry and biotechnological industries is one of the main goals of Synthetic Biology. Genetic 
code engineering has gained a lot of interest with the promise of expanding the code with the 
incorporation of unnatural amino acids into proteins with novel properties. Engineering of novel 
proteins with artificial non-canonical amino acids has been accomplished by two in vivo strategies: 
supplementation based incorporation method (SPI) and stop codon suppression approaches (SCS) 
(figure 3.1) (71).  
Several studies from Schultz and colaborators, have demonstrated that bacterial, fungal and 
mammalian cells are highly tolerant to incorporation of artificial amino acids at stop codons, using 
orthogonal tRNA-synthetase pairs that do not participate in conventional translation (72-74). In 
Escherichia coli, insertion of an orthogonal tyrosyl-tRNA synthetase (TyrRS) from Methanococcus 
jannaschii and a mutant tyrosine amber suppressor tRNA, allows the incorporation of synthetic 
amino acid O-methyl-L-tyrosine into proteins, in response to the amber codon UAG. Since the 
orthogonality prevents the new tRNA-synthetase from aminoacylating endogenous tRNAs and the 
new tRNA from being recognized by the host tRNA-synthetases, the system is highly specific (75). 
Anderson and co-workers were also able to engineer an orthogonal aaRS-tRNA pair derived from 
archaeal Lys-tRNA, which efficiently and selectively incorporated a non-canonical amino acid into 
proteins in response to the quadruplet codon AGGA (76). Genetic code engineering has also been 
achieved using an editing defective aaRS. Deletion of the editing domain of an isoleucyl-tRNA 
synthetase (IleRS) resulted in ambiguous translation of isoleucyl codons with non-canonical amino 
acids (77). These examples illustrate the efficiency of stop codon suppression (SCS) strategies 
(figure 3.1c).  
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On the other hand, supplementation based incorporation (SPI) strategies use auxotrophic 
strains and supplements the media with an isostructural non-canonical amino acid so that is not 
edited by aaRS. In this way, it is possible to exchange several residues in a protein by sense-to-sense 
reassignments, since it means the incorporation of artificial analogs (71). Indeed this methodology 
has been used, for example, to engineer mutant E. coli that incorporate selenomethionine instead 
of methionine (78), to engineer fluoropolymers using the non-canonical amino acid p-
fluorophenylalanine (79), and  the incorporation of labeled methionine analogs into proteins to 
allow structural and functional protein studies (80). However, due to the low efficiency and the 
inability to be site-specific, the results obtained from these approaches were rather disappointing 
and engineering of codon reassignments remains a significant experimental challenge (71). 
In this work, we used an alternative strategy of reassignment, similar to the one used by Geslain 
and coworkers for incorporation of serine at 19 different codons in chick embryos and human cells 
(81). We engineered ambiguous strains that misincorporate Ser at CUC-Leu and AGG-Arg codons in 
Figure 3.1 Aminoacylation with canonical (a) and non-canonical amino acids for protein translation by 
supplementation base incorporation (b) and stop codon suppression (c) techniques. Adapted from Hoesl 
and Budisa, 2012 
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a proteome wide fashion, using chimeric tRNAs. As SerRS does not interact with the anticodon of 
seryl-tRNAs, these can carry mutations in the anticodon as they do not affect their aminoacylation 
(81). Mistranslation induced on our model system involves the substitution of amino acids with 
different chemical properties, as highlighted in table 3.2 and figure 3.1, and it is expected to have a 
negative impact on cell fitness. In fact, according to the amino acid substitution matrix BLOSUM 62 
(82), replacement of leucine and arginine for serine has a substitution value of -2 and -1, 
respectively, which means these are, in fact, unfavoured events. 
 
 
 
 
3.2 Results 
3.2.1 Expression of mutant Ser-tRNAs in S. cerevisiae 
Since SerRS does not interact with the anticodon of tRNAs upon aminoacylation (84), this allows 
alterations in the anticodon of Ser-tRNAs without affecting their serylation. This makes C. albicans 
Ser-tRNAUGA a perfect tool for this project, as we can mutate its anticodon and thus reprogram it to 
misincorporate serine at the CUC-Leu and AGG-Arg codons lacking their cognate tRNAs. We chose 
this chimeric tRNA for the present study, as it does not contain introns and has 14 mismatches with 
the homologous tRNAUGA from S. cerevisiae, allowing for posterior detection of the mutant tRNAs 
by northern blot analysis, when expressed in S. cerevisiae.  
 Serine Leucine Arginine 
Polarity Polar Nonpolar Positive 
Side chain functional group -OH Methylene Methylene 
Molecular weight (D) 87 113 156 
Isoelectric point 5.7 6 10.8 
Polar requirement (83) 7.5 4.9 9.1 
Side chain flexibility Low Moderate High 
Table 3.1 Principal characteristics of amino acids involved in this study 
Figure 3.2 Structure of serine, leucine and arginine 
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So, mutant tRNAs were engineered by anticodon mutagenesis, generating Ser-tRNAGAG and Ser-
tRNACCU, and expressed in knock-out strains ΔtL(GAG) and ΔtR(CCU), respectively (figure 3.3), thus 
generating ambiguous strains. Mutant tRNAs were expressed in single and multi-copy plasmids 
(denoted as SC and MC, respectively), conferring two degrees of pressure when in competition for 
the targeted codon. In the Leucine set (strains based on ΔtL(GAG), figure 3.3, left panel), the unique 
Leu-tRNAGAG gene was deleted and so the three gene family tL(UAG) represent the only tRNA 
capable of decoding CUC codons with a relative strong codon-anticodon association (64). S. 
cerevisiae Leu-tRNAUAG is able to decode the four Leu-CUN codons by a superwobble mechanism 
(85), which is associated with its rare unmodified U34 (86). Analogously, the plastid Gly-tRNAUCC has 
an unmodified U34 and is also capable of decoding the four GGN-Gly codons, however it suggests 
that superwobbling decreases mRNA translational efficiency due to delayed recognition of U/C-
ending codons (87). So, in this work system, one can expect that mutant Ser-tRNAGAG will have the 
upper-hand in codon recognition competition, since CUC decoding by Leu-tRNAUAG is theoretically 
delayed and thus less efficient.  
 
 
 
On the other hand, in the Arginine set (strains based on ΔtR(CCU), figure 3.3, right panel), AGG-
Arg codon is decoded by Arg-tRNAUCU in the absence of Arg-tRNACCU, by standard wobble rules (64). 
Its anticodon position 34 is methylated (mcm5U) by Trm9, which enables decoding of G-ending 
codons by Arg-tRNAUCU (88). It has been shown that AGG decoding by Arg-tRNAUCU is especially 
Figure 3.3 – Representation of mutant tRNAs in the strain background of this work. A series of 
misreading tRNAs were engineered from Ser-tRNAUGA by site directed mutagenesis of its anticodon to 
GAG and CUC, misincorporating serine at Leu and Arg sites respectively. These codons do not have their 
cognate tRNAs and their decoding is being compensated by tL(UAG) and tR(UCU) families, respectively  
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inefficient and causes translational pausing that promotes frameshift +1 (89, 90). Again, in codon 
competition, it is expectable the advantage of mutant Ser-tRNACCU since codon-anticodon 
interaction is stronger due to the G-C pair formed in the wobble position, instead of the less stable 
mcm5U-G pair formed by Arg-tRNAUCU (89).  
Along with the mutant tRNAs, yeast strains were also transformed with the empty multi-copy 
vector pRS426 (denoted as EV) and the original WT Ser-tRNAUGA. Subsequently, five clones from 
each transformation were selected. To assess the impact of the mistranslating tRNAs in S. cerevisiae 
fitness, growth curves parameters were evaluated.  
 
 
3.2.2 Leucine set 
As expected, different expression levels of the misreading tRNA had different fitness costs to the 
cell, as seen in figure 3.4. Also, the deletion strain ΔtL(GAG) showed a growth profile similar to the 
wild-type Y5565, as previously reported (64, 91). There was a strong negative impact in cells highly-
expressing Ser-tRNAGAG (ΔtL + MC-tRNAGAG) whereas its single-copy counterpart (ΔtL + SC-tRNAGAG) 
had little impact in growth rate (figure 3.4B). Surprisingly, overexpression of the endogenous Ser-
tRNAUGA at high level exerted a similar decrease. Indeed, in the two highly expressing strains (ΔtL + 
MC-tRNAUGA and + MC-tRNAGAG), growth rates dropped to around 55% relative to the wild-type 
strain (figure 3.4B).  
Misincorporation of serine at Leu sites involves substitution of chemical distinct amino acids, as 
highlighted in table 3.1, and so it was expected the subsequent cost in cell fitness. Oddly, this type 
of mistranslation in a low expressing system (ΔtL + SC-tRNAGAG) did not had impact in growth when 
compared to the deletion strain (ΔtL(GAG)). Bloom-Ackermman and colleagues reported that 
strains with deletions of single-copy tRNA genes, namely ΔtL(GAG) and ΔtR(CCU), have reduced 
sensibility to proteotoxic agents. This led them to hypothesize that these cells are already under 
chronic misfolding stress, which in turn offers cross-protection to further extrinsic proteotoxic 
stress (64). This may be the reason for the lack of observable phenotype in growth rate of the single-
copy group, as the cells may be “programmed” to better respond to further proteotoxic stress, as 
the incorporation of an erroneous amino acid in a proteome-wide manner. Our results show that 
this may be true to some extent, as the over expression of the mutant tRNA abolishes this 
“protection” phenotype.   
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One striking feature that arose from growth curves profiles (figure 3.4A) were the drastic 
differences in the duration of lag phase (figure 3.4C). The duration of a lag phase is indicative of the 
time needed to reprogram transcription, and so adapt to new challenging conditions (92). Also, the 
extended lag phase duration indicates that these strains may have defects in metabolism or in cell 
cycle progression (93).  
 
 
3.2.3 Arginine set 
As previously reported (64, 90), deletion of the gene encoding Arg-tRNACCU has a significant 
negative impact in growth rate (figure 3.5) when compared to the wild-type Y5565. However, the 
Arginine set does not show the same behavior as the Leucine mutants. Also, results from this set 
Figure 3.4 – Impact of mutant tRNAs on cell fitness of ΔtL(GAG) mutants. (A) Growth curve 
measurements represented as optical density (OD) units over time. (B) Growth rate of leucine mutants. 
Data represents the mean + SD of 5 different clones. ***P <0.001, one-way ANOVA post-Dunnet 
comparison test with 95% confidence interval relative to ΔtL(GAG) cells. (C) Lag phase duration of leucine 
mutants, in hours. 
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should be taken carefully and with some reserves, since the strain transformed only with the empty 
plasmid (ΔtR + EV) is one of the major growth incapacitated strains (figure 3.5A and B). This odd 
feature was confirmed with three more new independent transformations. We also tested the 
effect of transforming the empty vector pRS426 in other strains to determine if this phenotype was 
intrinsic to the knock-out strain ΔtR(CCU). Transformation with the empty vector was performed in 
two other deletion strains of Leu and Arg-tRNA genes, ΔtL(UAG)J and ΔtR(UCU)M2, respectively. 
The tL(UAG)J gene encodes one of the copies of the three gene family tRNALeuUAG, while tR(UCU)M2 
encodes one of the copies of the eleven gene family tRNAArgUCU, and was characterized as a “major 
copy”, by Bloom-Ackermman, since its deletion had a significant growth impact in comparison with 
other copies from the same family (64). The growth rate of all these was not altered by the insertion 
of the plasmid, so the reported result must be due to some constraints in the ΔtR(CCU) strain. One 
hypothesis to explain this result might be related to the selective marker of the vector, URA3. This 
Figure 3.5 – Impact of mutant tRNAs on cell fitness of ΔtR(CCU) mutants. (A) Growth curve measurements 
represented as optical density (OD) units over time. (B) Growth rate of arginine mutants. Data represents 
the mean + SD of 5 different clones. ***P <0.001; *P <0.05 , one-way ANOVA post-Dunnet comparison test 
with 95% confidence interval relative to ΔtR(CCU) cells. (C) Lag phase duration of arginine mutants, in hours. 
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gene encodes the OMP (orotidine-5'-phosphate) decarboxylase, which is involved in uracil 
synthesis, and its Arg-247 residue is encoded by the codon AGG (94). So, one possible explanation 
is that the decoding of this codon is highly affected by the absence of its cognate tRNA, in a way 
that would render part of the enzyme population as not functional. If so, cells would show huge 
growth defects in selective media lacking uracil, like the case, as they are defective in its production, 
and consequently represent a situation of nutrient starvation. Consequently, the growth profile 
shown in figure 3.5 may represent a situation of nutrient starvation. Unfortunately, there is no 
evidence to corroborate this hypothesis as further studies would be needed. 
Hereupon, similarly to the Leucine set, strains expressing the mutant Ser-tRNACCU (ΔtR + MC-
tRNAccu) and Ser-tRNAUGA (ΔtR + MC-tRNAUGA) at high level exhibited the highest impact on growth 
rate, corresponding to a decrease in ~65% relative to WT cells (figure 3.5B). Although there was a 
visible impact in the duration of the lag phase (~10 more hours than the WT and knock-out strains) 
(figure 3.5C), the impact of MC-tRNAUGA was less pronounced that in its counterpart in the Leucine 
set (figure 3.4C).  
Another difference is the heterogenous impact of Ser-tRNACCU in strains expressing it at low 
level. As seen in figure 3.5A, the behavior of the five clones was different, which led to their division 
in two sub-sets (ΔtR + SC-tRNAUGA). Three clones belong to the first sub-set that was less affected 
(~30% decrease in growth rate relative to WT) and the two other clones were affected to an extent 
similar to when expressed in high level (~50% decrease in growth rate relative to WT). Altogether, 
these results indicate that ΔtR(CCU) strain has a different way to cope with mistranslation that 
ΔtL(GAG) strain. 
 
 
3.2.4 Impact of CUC and AGG ambiguity 
The results presented above shows that ambiguous strains tolerate the misincorporation of Ser 
at Leu-CUC and Arg-AGG codons, although with high negative impact to cell fitness. Therefore, to 
better understand the impact of ambiguous decoding of these codons, and to obtain a picture of 
its effect on S. cerevisiae biology, we studied the genomic distribution and the usage of these 
codons using the ANACONDA software developed by the Bioinformatics group of Aveiro (95). All 
the analysis were carried out using the reference genome sequence of Saccharomyces cerevisiae 
strain S288C, available at the Saccharomyces Genome Database (SGD, http://yeastgenome.org/).  
Analysis with ANACONDA identified 6689 genes in the S. cerevisiae genome, and codon 
distribution analysis revealed that its genome contains 17499 CUC codons distributed throughout 
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77% of its genes (figure 3.6A). Leu-CUC usage frequency is only 5.5‰ and, therefore, belongs to the 
category of rare codons. Indeed, most of yeast genes (64.8%) has between 1 to 5 codons, and only 
2.4% has more than 10 CUC codons on their ORFs. One the other hand, Arg-AGG usage frequency 
is a bit higher but still only scores 9.2‰, therefore is still considered a rare codon in yeast (96). 
Here, ANACONDA codon distribution analysis revealed that its genome contains 28483 AGG codons 
distributed throughout 84% of its genes (figure 3.6B). Like as CUC, the majority of its genes (56.2%) 
has 1 to 5 codons. But contrary to CUC distribution, 8.4% of yeast genes has more than 10 AGG 
codons. 
 
 
 
Apart from the major decrease seen in growth rate of strains with high expression of mutant 
Ser-tRNAs, one of the most notorious and unexpected phenotypes was the major increase in the 
duration of the lag phase. Ma and colleagues reported that S. cerevisiae with defective cAMP-
dependent protein kinase activity had slow glucose uptake and extended lag phases (93). The 
cAMP-protein kinase A (PKA) pathway in yeast plays a major role in the control of metabolism, 
stress resistance and proliferation and so, we looked for S. cerevisiae genes related to PKA in the 
National Center for Biotechnology Information (NCBI) genes database which retrieved a group of 
52 genes (complete table 3.1 in annex). Analysis of this group with ANACONDA revealed a different 
tendency in CUC codon distribution from that in the genome. The majority of these genes have 1 
to 5 CUC codons (59.6%) like previously, but the frequency of genes with 6 or more CUC codons 
increased 10%. Interestingly, almost 10% of this group of genes has more than 10 CUC codons 
Figure 3.6 – Leu-CUC (A) and Arg-AGG (B) codon distribution over S. cerevisiae genome. In the yeast 
genome almost one fourth of its genes do not have CUC codons, while almost one sixth do not have AGG 
codons. The majority of its genes, 64.8% in the case of CUC and 56.2% in the case of AGG, contains 1 to 5 
codons (orange and blue groups), while 9.9% and 19.6% of its genes have 6 to 10 CUC and AGG codons, 
respectively (yellow group), and only 2.4% of its genes have 10 or more CUC codons, while in the case of 
AGG, 8.4% of its genes have 10 or more CUC codons (green and red groups). 
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(figure 3.7A), which is discrepant from the frequency seen in the genome (figure 3.6). Genes from 
this group show a distribution of AGG codon content even more discrepant. Here, genes with 1 to 
5 AGG codons (46.2%) have almost the same frequency as genes with more than 6 codons (36.5%), 
while one fourth of them has more than 10 codons. 
So it is likely that the uncovered group of genes with high number of CUC and AGG codons 
(particularly those with 10 or more codons) are specially affected by Ser misincorporation at these 
sites. Table 3.2 shows the identified genes with more than 6 CUC codons, their respective number 
of AGG codons, the number of codons in their ORFs and their respective biological description. As 
results obtained from the Arginine set are rather dubious due to the expression of the empty vector, 
Figure 3.7 – CUC and AGG codon distribution over the PKA related genes group (A) and a schematic of 
the Ras/cAMP/PKA pathway (B) (adapted from Pescini et al., 2012). (A) Contrary to the tendency in the 
genome, 23% of this group has more than 6 CUC codons in their genes, while 36.5% has more than 6 AGG 
(yellow and green groups). (B) Proteins highlighted in the Ras/cAMP/PKA pathway were identified with 
high number of CUC and AGG codons, as shown in table 3.2. 
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we focused particularly in CUC-Leu codons, although the same thought can be extrapolated to the 
Arginine set due to the high number of AGG codons accounted in these genes. Crucial genes 
involved in the Ras/cAMP/PKA pathway were identified (figure 3.7B and table 3.2), like CYR1 (with 
16 CUC codons) which encodes the adenylate cyclase that synthetizes cAMP and therefore activates 
PKA (97), IRA2 and its paralog IRA1 (with 22 and 19 CUC codons, respectively) which encodes 
GTPase activating proteins that negatively regulate the activity of Ras proteins (98), and CDC25 
(with 6 CUC codons) which encodes a guanine nucleotide exchange factor that positively controls 
Ras activity by stimulation of GDP–GTP exchange (99). Therefore, this metabolic pathway is 
probably impaired in our mutant strains and they are expected to have lower levels of intracellular 
cAMP than WT and deletion strains. So, although PKA itself is not affected by CUC codon content 
(catalytic subunits TPK1/2/3 have none or one CUC, while its regulatory subunit BCY1 has 5 CUCs, 
as seen in in table 3.3 in annex), the impaired supply of cAMP may compromise PKA activity which 
is dependent of cAMP. Low PKA activity has been shown to stop growth in yeast by arresting cells 
in a G1 quiescent state, similar to G0 in higher eukaryotes (100), which is in accordance with our 
results from extended lag phases, but differs from our mutant strains as they were not permanently 
arrested. 
 
 
3.3 Discussion 
Mistranslation is expected to be toxic to the cell and to have a deleterious effect in cell growth 
rate. For example, mistranslation at CUG-Leu codons, in S. cerevisiae induced by the expression of 
the C. albicans Ser-tRNACAG caused a decrease of around 50% in growth rate and triggers the stress 
response. It is noteworthy that this pronounced impact is a result of the tRNA expression in a single-
copy plasmid.  (57). So, in our low expression system, one should expect a strong decrease in growth 
rate due to mistranslation, which was not the case. In our Leucine system, low expression of 
misreading tRNAs did not have an impact in fitness, when compared to the knock-out strain, which 
is also true for part of the ΔtR clones (subset 1 of single-copy tRNACCU). These results can be 
explained by the fact that the knock-out strains used in this study are already in a state of chronic 
stress, which rendered them less sensitive to proteotoxic agents (64). Microarray data showed that 
pathways responsive to proteotoxic stress, such as the proteasome and protein processing in ER, 
are up-regulated in these strains (64). So, since cells have already the stress pathways activated, 
they are able to better cope with a further proteome destabilizing agent, such as the low expression 
of our mutant tRNAs.  
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On the other hand, the arginine single-copy mutants showed a pronounced heterogeneous 
growth rate and lag phase duration. Organisms respond to environmental changes by adapting the 
expression of key genes. However, such transcriptional reprogramming is energetically costly and 
decreases cell fitness (92). The heterogeneity observed can indicate that cell may be 
“experimenting” different metabolic reprogramming, like seen in response to changing carbon 
environments (92).  
Howsoever, the overall behavior of arginine mutants was different from the one exhibited by 
leucine mutants. Apart from the stronger decrease in growth upon gene deletion, the microarray 
data collected by Bloom-Ackermman and colleagues, shows that mRNA expression of ΔtR(CCU) is 
much more deregulated than in ΔtL(GAG) (64), possibly rendering the first more sensible to further 
aggression. But contrary to this notion, ΔtR(CCU) shows high tolerance to proteotoxic agents like 
DTT (reducing agent), AZC (toxic analog of proline) and tunicamycin (induces the unfolded protein 
response in the ER) (64). However, in the un-engineered ΔtR(CCU) strain, AGG decoding is being 
compensated by an iso-acceptor tRNA which inserts arginine at low efficiency, so the overall effects 
are not comparable to our system, since these codons are being decode as serine. So, one 
hypothesis is that AGG codons are present in specific sites that are less tolerant to point amino acid 
substitutions. 
In both groups, strains expressing the mutant tRNA at high level had a strong negative impact 
on growth rate and on the time required to enter the exponential phase, but remained viable. 
Extended lag phases have been reported in Saccharomyces cerevisiae with deficient cAMP-
dependent protein kinase activity (93). Accordingly, analysis of CUC and AGG codon content in PKA 
related genes revealed a trend that culminates in lowering PKA activity, particularly by possible 
disruption of the adenylate cyclase responsible for cAMP synthesis (CYR1). In S. cerevisiae, a normal 
activity of PKA is required for growth and cell cycle progression, while a reduction of its activity, 
related to a decrease of intracellular cAMP, results in the accumulation of storage carbohydrates, 
high stress tolerance and arrest of growth and cell cycle (100). Several genes with high frequency 
of these codons are directly or indirectly related to the cAMP pathway and have high biological 
relevance. For example, GPR1 is a membrane receptor, part of the glucose-sensing system together 
with GPA2, which regulates cellular cAMP level by stimulation of cAMP synthesis (101), which also 
suggests that glucose sensing may be impaired in our mutants.  
Interestingly, major destabilizations in the endogenous tRNA pool accomplished by highly 
expressing the endogenous Ser-tRNAUGA, also had a strong impact in cell fitness. In fact, these 
strains were the most affected and exhibited the longest duration in lag phase. For example, the 
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Leu mutant (ΔtL + MC-tRNAUGA) took an astonishing 40 hours to adapt to their new genetic condition 
and so enter in the exponential phase (figure 3.4C). One can rationalize that as cells, prior to 
expression of mutant Ser-tRNAs, are already deficient at decoding of CUC and AGG codons and are 
under proteotoxic stress due to elimination of their cognate tRNAs (64), so the accurate decoding 
of the highlighted genes related to PKA metabolism is already compromised. This may indicate that 
destabilization of the endogenous tRNA pool may induce further defects in metabolism and/or cell 
cycle progression, and that the molecular mechanisms employed by the cell to counteract such 
destabilizations are energetic and time costly to the cell, as reflected by their growth rates. 
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Chapter 4 
 
4. Evolution of codon ambiguities 
 
4.1 Overview 
The host laboratory has made a major breakthrough by engineering the first complete codon 
reassignment. Using tRNA engineering and gene deletion, they constructed a series of C. albicans 
strains that misincorporate Leu at the atypical Ser-CUG sites, at levels that range from 20% up to 
99%. Surprisingly, these strains adapted to increasing Leu misincorporation, recovered growth rate 
to wild-type levels and displayed unanticipated phenotypic variability, including highly variable 
colony and cell morphologies, and increased tolerance to antifungals (58). As suggested by this and 
other studies (57, 70, 102), proteome destabilization produced by codon ambiguity is at some 
degree tolerable, and can be advantageous in some circumstances. So it has been suggested that 
codon ambiguity provides a mechanism to codon evolution, as far as the universe of statistical 
proteins produced provides phenotypic variability and innovation that allow organisms to explore 
new environments (48, 58, 103). Additionally, genome re-sequencing of the reassigned C. albicans, 
engineered by Bezerra and colleagues, showed rapid accumulation of unique single nucleotide 
polymorphisms (SNPs) and loss of heterozygosity (LOH) with increasing CUG ambiguity (58). These 
data show an intrinsic link between the genome and the genetic code, and support the hypothesis 
that codon reassignments can be engineered using forced evolution, releasing the code its frozen 
state. 
Here, we will test the hypothesis that codon reassignments can be engineered using forced 
evolution, by subjecting the ambiguous strains described in chapter 3 to experimental evolution. 
These strategies allow the maintenance of yeast populations over timescales spanning many 
hundreds or even thousands of generations, in which changes in both genotype and phenotype can 
be monitored. There are three main strategies to propagate organisms in experimental evolution 
studies, which explore different types of genetic dynamics (figure 4.1) (74). In mutation 
accumulation experiments (figure 4.1a), the effects and rates of a new mutations are studied by 
imposing population bottlenecks. These minimize the size of the population which reduces genetic 
diversity and may lead to the fixation of arbitrary mutations (75). In adaptive evolution 
experiments, the genetic dynamics are driven by preferential accumulation of mutations that are 
better adapted to certain environments. Our evolutionary experiment is part of the last group and 
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was made by serial transfer (figure 4.1c), in which a part of the yeast population is periodically 
transferred to fresh media and allowed to regrow until the limiting nutrient is exhausted. By doing 
so, the genetic diversity is maintained at each transfer (104). 
 
 
 
 
4.2 Results 
4.2.1 Evolution of the Leucine set 
Cells were subjected to experimental evolution, until they reached ~200 generations. After this 
point was reached (around 20 passages, every 2-3 days depending on the duration of the lag phase) 
the fitness parameters were accessed again. As before, low and high expressing groups had 
different behaviors.  
After evolution, low expressing strains (SC) showed a similar trend to the control strains 
ΔtL(GAG)G and ΔtL+EV (figure 4.2), that is a small decrease in growth rate when compared to their 
non-evolved counterpart. ΔtL(GAG)G had a 4% decrease, while ΔtL+SC-tRNA(GAG) showed a ~14% 
decrease in growth rate after evolution (paired t-test, P=0.008). ΔtL+EV and ΔtL+SC-tRNA(GAG) had 
25% and 19% decrease in growth rate, respectively. This behavior is completely different from the 
observed in the high-expressing group (MC), where an increase in growth rate was observed in 
comparison to their non-evolved counterpart. This shows that cells coped differently with different 
levels of the same tRNA.  
Figure 4.1 – Different types of experimental evolution.  Adapted from Barrick et al., 2013. (a) Mutation 
accumulation experiments. (b and c) Adaptive evolution by (b) continuous cultures and by (c) serial 
transfer.    
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Strains expressing both Ser-tRNAUGA and Ser-tRNAGAG at high level, recovered significantly in 
several growth parameters after 200 generations. Indeed, EΔtL+MC-tRNA(UGA) and EΔtL+MC-
tRNA(GAG) recovered approximately 15% and 25% of their growth, respectively (paired t-test, 
P=0.03 and P=0.0014, respectively). In this way, cells expressing the mutant tRNA at high level 
reached growth rate levels similar to the observed in the deletion strain ΔtL(GAG)G. Although these 
strains did not achieve WT growth rate levels, this astoneshing recovery led us to hypothesize that 
it may take more time to fully achieve the adapted state. So it would be interesting to evaluate their 
behavior after another round of evolution. Our thought is that these ambiguous strains would 
accumulate a series of beneficial mutations that would adapt translation to the new genetic 
background, as in the work of Bezerra and coworkers (58).  
Another surprising recovery seen in these MC strains is in the duration of the lag phase (figure 
4.3). Particularly, clones overexpressing the endogenous Ser-tRNAUGA (ΔtL+MC_tRNA(UGA)) took 
less than half the time required in the beginning of the experiment to enter exponential. Although 
less pronounced, cells highly expressing the mutant Ser-tRNAGAG also exhibited a recovery in this 
parameter, cutting almost 10 hours in the duration of lag phase. Together with their recovery in 
growth rate, this shows that these strains can adapt to the induced mistranslation. Similar results 
relative to this phase have been obtained after evolution of E. coli with extended lag phases. Also, 
accordingly with the reported in E. coli (105), these high-expressing strains showed a detectable 
recovery on the duration of this phase, as early as after 5 passages (105). Unfortunately, we only 
have data at mid-point evolution from the strain expressing Ser-tRNAUGA, with ~120 generations, 
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Figure 4.2 – Comparison between the growth rate of non-evolved (grey) and evolved (black) Leucine 
mutants. Data represents the mean + SD of 5 different clones. 
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and at this point they already had cut half of time required to enter exponential phase. As seen in 
bacteria, adaptations that reduce lag phase are highly beneficial, and are readily fixed before 
adaptations that benefit growth rate (105). However, the behavior of growth rate levels of our 
mutant strains were heterogeneous across clones (figure 4.4). Indeed, at half-time experiment 
(100G), each clone showed recovery rates ranging increases from 10% to 30%, relative to the non-
evolved strain (blue bar in figure 4.4). Interestingly, the one clone that showed the highest growth 
recovery (31%) at generation 100 (clone 2), then slightly decreased the recovery (~8% compared to 
100G) in the end of the evolution. The other clones had a more moderate recovery at half-time 
evolution, and interestingly the clone who recovered less in the first phase (clone 1), was the one 
showing the better performance at the end of the experiment (with an overall increase of 32% 
relative to non-evolved clone, and around 20% recovery in the second phase).   
 
 
 
Another difference between the two multi-copy strains is how clones from the two strains cope 
with mistranslation. As seen in figure 4.5, clones highly expressing the mutant tRNA after evolution 
(EΔtL+MC-tRNA(GAG)) constitute a more homogeneous population than clones overexpressing the 
endogenous tRNAUGA. This subtle feature may indicate that different biological mechanisms may be 
at hands. Half of the clones overexpressing the endogenous Ser-tRNA had a better performance 
(recovered ~25% of their growth rate) and reached a higher growth yield (final OD600, which 
indicates the amount of biomass produced) than the other half, which only recovered ~15% of their 
growth rate (figure 4.5B). On the other hand, clones with high expressing of the misreading tRNA 
are a homogeneous population (figure 4.5A), which may indicate that the same mechanisms and 
mutations are involved in adaptation to mistranslation in all clones. 
Figure 4.3 – Comparison between the lag phase duration, in hours, of non-evolved (dark grey) and 
evolved Leucine mutants (light grey). Data represents the average of 5 different clones. 
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4.2.2 Evolution of the Arginine set 
Contradictory to the work done by Yona and colleagues (106), we did not see the recovery of 
the deletion strain ΔtR(CCU) after evolution to WT levels. Indeed, here, evolved ΔtR(CCU) (EΔtR) 
shows a slight decrease and a homogenization of the population (figure 4.6).  Again, strains 
expressing tRNAs at low level (SC) did not exhibit meaningful growth phenotypes. The only 
Figure 4.4 – Comparison between the growth rate of non-evolved ΔtL strains highly expressing the 
endogenous Ser-tRNAUGA (blue bar), and evolved strains with 100 (orange bar) and 200 generations 
(grey bar). Each clone is normalized to its non-evolved form. 
Figure 4.5 – Comparison between the growth curve profiles of non-evolved (ΔtL, light blue) and evolved 
(EΔtL) Leu mutants. Growth curve measurements as optical density (OD) units over time of mutants 
highly expressing Ser-tRNAGAG (A) and Ser-tRNAUGA (B). Non-evolved data represents the average ± SD of 
5 different clones (light blue line) 
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observation of note, is that beside the decrease seen in growth rate of ΔtR+SC-tRNA(CCU), the 
population became more homogeneous and intriguingly fixated in lower growth phenotype. 
As in the Leucine set, strains expressing the tRNAs at high levels (MC) showed a significant 
recovery in growth rate (paired t-test, ΔtR+MC-tRNA(UGA) vs. EΔtR+MC-tRNA(UGA): P=0.027; and 
ΔtR+MC-tRNA(CCU) vs. EΔtR+MC-tRNA(CCU): P=0.043). However, the pattern of alteration in the 
duration of the lag phase (figure 4.7) is not like the one of the Leu set, highlighting the development 
of different metabolic and genetic networks in the Arg set. For example, a different mechanism may 
be at play in cells expressing Ser-tRNACCU at high level, as they recover their growth rate without 
altering the time required for entering exponential phase. This is also contrary to the E. coli study, 
where lag phase adaptations are always fixed before growth rate improvements (105). 
 
 
 
Cells overexpressing the endogenous tRNA were the ones that showed the highest recovery in 
both parameters (figures 4.6 and 4.7). Still, like in the Leucine set, the population was 
heterogeneous and could be divided in two sub-sets, according to growth rate: one that recovered 
~25% of their initial growth rate, and other that surprisingly recovered ~60% (data not shown). So 
it seems that in the genetic background of ΔtR(CCU), destabilizations in the endogenous tRNA pool 
are better tolerated than substitutions of Arg to Ser in response to codons AGG, unlike the Leucine 
set. 
 
Figure 4.6 – Comparison between the growth rate of non-evolved (grey) and evolved (black) Arginine 
(ΔtR) mutants. Data represents the mean + SD of 5 different clones. 
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4.2.3 Northern blot analysis of mutant tRNA expression 
Several mechanisms may be behind the recovery in fitness of the evolved mistranslating strains. 
Robustness may emerge from various processes, from transcription level to changes in the 
chaperone system. Other hypothesis is the mitigation of the error rate during the evolution by 
decreasing expression of the mutant tRNA. To verify if the growth recovery observed in the multi-
copy expressing strains could be due to a decrease in the chimeric tRNA expression, a northern blot 
analysis was performed. All tRNAs were detected, which shows that in fact they are being expressed 
and the observed fitness phenotypes, both before and after evolution, are attributable to the 
mutant tRNA (figure 4.8).  
Interestingly, expression of Ser-tRNAGAG appears to increase after evolution. Indeed, 
quantification by ImageJ software showed an increase in Ser-tRNA expression in all evolved strains. 
The huge increase seen in the evolved strains expressing Ser-tRNAUGA and Ser-tRNAGAG (clone3) may 
be due to bad quality sample, as blots appear as smears. The other two evolved clones with high 
expression of the mutant Ser-tRNAGAG (EΔtL+Ser-tRNAGAG) showed increases of 30% and 78% in 
expression. This may indicate that these cells have adapted to mistranslation, and somehow have 
selected it as beneficial during evolution. Together with the previous results, the hypothesis of a 
codon reassignment, at least at some degree, seems more promising. 
The Arginine set behaved differently in the tRNA expression parameter too. To alleviate the 
deleterious impact of mistranslation, the trend revealed by this set seems to culminate in lowering 
the expression of the mistranslating tRNA. Consistently, evolved mutants expressing Ser-tRNACCU 
Figure 4.7 – Comparison between the lag phase duration, in hours, of non-evolved (dark grey) and 
evolved (light grey) Arginine mutants. Data represents the average of 5 different clones. 
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showed a decrease of around 40% in tRNA expression, while the tRNA disrupting the endogenous 
tRNA pool showed a more modest decrease of 20%. Again, striking differences arose from the two 
sets, indicating that different cellular and molecular mechanism may be at action. 
 
  
 
 
4.2.4 Mutant tRNA sequencing 
To monitor if the inserted tRNAs were mutated or degraded, and so validate these experiments, 
we extracted the plasmids containing the engineered tRNAs from non-evolved and evolved yeast 
mutants, and sequenced them. Unfortunately, strains from the arginine set did not exhibit the 
altered anticodon, which invalidates data relative to the mutant Ser-tRNACCU set. Since the 
constructed plasmids were sequenced and validated prior to cloning experiments, so one out of 
two possibilities exist: or strains unexpectedly reverted the codon identity of engineered tRNAs, or 
it could be a simple human error in the begging of the experiment or during plasmid extraction. 
Still, data from strains overexpressing Ser-tRNAUGA are still valid. Indeed, beside the disappointing 
Figure 4.8 – Northern blot analysis of the mutant tRNAs. Northern blot hybridizations were carried out 
using ɣ-32P-ATP-tRNAUGASer (oUA2199) and ɣ-32P-ATP-tRNACCCGly (oUA2195) probes. Panel 1 shows the 
hybridization membranes from the Leu set (A) and their intensity quantification (B). Panel 2 shows the 
hybridization membranes from the Arg set (C) and their intensity quantification (D). Quantification of 
each pair of un-evolved (dark grey) and evolved clones (light grey) were normalized to the respective 
non-evolved version (=1) 
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sequencing results, strains expressing Ser-tRNAUGA and Ser-tRNACCU showed bifferent dehaviours 
consistently. But still we decided to not use this set in further analysis. 
 
 
 
The totality of the Leucine set was validated by sequencing. Interestingly, we found that all the 
non-evolved and evolved clones expressing Ser-tRNAGAG in a multi-copy plasmid acquired a 
mutation C→U in position 62, which is located in the TψC arm (figure 4.9). Yap and colleagues 
mutagenized this position to other nucleotides in E. coli Pro-tRNA and concluded that as long as 
wobble pair is maintained, like G52-U62 seen in our mutant tRNA, no major defect is seen in the tRNA 
aminoacylation (107). Singh and Green also reported that the C62U mutant of Met-tRNAi had no 
defect in nuclear export (108). The only functional implication found across the bibliography was 
its influence in modifications in position 55 of the T-loop, and at a less extent in position 54. Becker 
and coworkers constructed a series of mutant T-loop mini-helixes as substrate for the modification 
enzymes m5U54-methyltransferase and ψ55-sintetase, and found that the introduction of a wobble 
Figure 4.9 – Sequencing data from strains highly expressing Ser-tRNAGAG and the theoretical structure 
of the mutant tRNA. First line of the sequencing data is relative to the WT Ser-tRNAUGA, while the others 
show a representative sample of non-evolved and evolved clones highly expressing Ser-tRNAGAG. C to U 
mutation and the anticodon are highlighted both in the sequencing data and in the tRNA structure.  
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pair G52-U62, in place of a Watson-crick pair G52-C62, dramatically decreased (but did not abolished) 
the efficiency of ψ55 formation in yeast Asp-tRNAGUC (109). Pseudouridine-55 is found in almost all 
tRNA species from yeast (110) (except in the initiator Met-tRNA (111)) and contributes to the 
stabilization of specific structural motifs in the TψC-loop (111, 112). Noteworthy, the disruption of 
the yeast gene PUS4, encoding the sole enzyme capable of ψ55 synthesis, has no effect on cell 
growth. Given its almost universal conservation, this is somehow unexpected, but previous studies 
had already shown that the absence of ψ55 does not impact tRNA aminoacylation, nor it affects 
translation in vitro (113). So the functional consequences of the mutation found in all the clones 
remains a mystery, but its degree of homogeneity implies that they are in fact functional, and may 
be linked to fine-tuning of specific steps in protein synthesis (113). 
 
 
4.2.5 Monitoring of Ser misincorporation  
In order to monitor Ser misincorporation by at CUC-Leu and AGG-codon in cells with high 
expression of mutant tRNAs, we engineered a reporter system based on the yeast-enhanced green 
fluorescent protein gene (yEGFP) (114).  
Before we knew the sequencing results from the Arginine set, we had already constructed the 
reporter system for this set (figure 4.10). Although the results obtained from the strains expressing 
the mutant tRNA are not valid, this method seems suitable to this kind of study and can be used in 
future studies. Position 96 of GFP has been reported as critical to proper chromophore formation, 
and only exhibit fluorescence if Arg or Lys are incorporated at this position. Since any other amino 
acid substitutions produces inactive and non-fluorescent proteins, the authors rationalized that the 
mutant proteins did not properly fold or were poorly expressed (115). So the manipulation of the 
codon encoding this residue seemed perfect to monitor misincorporation of Ser residues instead of 
the Arg ones. Indeed, the mutagenesis of the AGA-Arg codons to UCU-Ser codons rendered cells 
with no fluorescence, contrary to cells expressing the wild-type version of GFP, where these codons 
are decoded as Arg.    
In the case of the Leu set (figure 4.11), we engineered position 201 of GFP, which is encoded by 
a UUA-Leu codon, as it was described as critical to protein stability and any substitution renders 
GFP inactive (114). We used a similar strategy reported by the host laboratory (58), but in this case, 
the reporter system is a loss-of-function one. For this, we mutated the codon encoding residue 201 
to the “orphan” CUC-Leu codon. This GFP version serves as a reporter, because if Ser is inserted by 
the mutant Ser-tRNAGAG in the place of Leu, cells would have no fluorescence, allowing us to 
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monitor its misincorporation. As a negative control, we constructed a UCU codon at this position, 
which is always decoded as Ser, leading to the quick GFP degradation (58).   
 
 
 
 
 
In order to express the plasmids harboring the GFP constructions in evolved cells, we first had 
to remove the plasmid containing the mutant tRNA, as both vectors carry the URA3 marker. 
Following the notion that toxic plasmids are promptly discarded by cells grown in media without 
selection, we first grew them in YPD and after a few passages, colonies where again stroked in the 
selectable media. Surprisingly, cells did not lose plasmid across 20 passages (corresponding to 
almost ~200 generations, another round of evolution). This is indicative that evolved strains (and, 
at a lesser extent, un-evolved strains) are strongly selecting the mutant tRNA across generations, 
Figure 4.10 – Scheme of the reporter system built to monitor serine incorporation at AGG-Arg codons. 
The system is based on the plasmid pACT1-GFP, which contains the codon-optimized yeast enhanced 
green fluorescent protein (yEGFP) (47). The arginine-96 is encoded by the AGA-Arg codon which was 
mutated to UCU-Ser (negative control) and to the “orphan” AGA-Arg codon (reporter). 
Figure 4.11 – Scheme of the reporter system built to monitor serine incorporation at CUC-Leu codons. 
The system is based on the plasmid pACT1-GFP, which contains the codon-optimized yeast enhanced 
green fluorescent protein (yEGFP) (47). The leucine-201 is encoded by the UUA-Leu codon which was 
mutated to UCU-Ser (negative control) and to the “orphan” CUC-Leu codon (reporter). 
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even when not exposed to selective conditions. Consequently, we then used a more efficient 
technique. Cells were then plated in 5-FOA plates, which only enables growth of ura3-, since it is 
converted by the enzyme encoded by URA3 to fluorodeoxyuridine, which is toxic to cells (116).   
 
 
 
Surprisingly, evolved strains expressing the mutant Ser-tRNAGAG exhibit the same behavior as the 
negative control, showing a complete loss of GFP function (figure 4.12). This indicates that mutant 
tRNAs are indeed incorporating Ser at CUC-Leu codons. In fact, these results imply that Ser 
miscorporation increased nearly to 100%, which indicates that this strains may have possibly 
achieved codon reassignment. However, these exciting results must be taken carefully, as this 
reporter system is not perfect, and is merely indicative. As one can see in the representative picture 
on figure 4.12, fluorescence is very heterogeneous and its signal is not homogeneous across the 
cell cytoplasm (for example, GFP does not seem to enter vacuoles). So, isogenic cells in one 
population show a broad range of fluorescence, indicating that this system is highly unstable. A 
good approach to this problem would be by expressing yEGFP using an integrating strategy, like 
previously used (58). Unfortunetly, transformations of non-evolved and evolved knock-out strains 
with the complete set of control plasmids (harboring only the different versions of GFP) proved 
recurrently unsuccessful. So apart from the innerent frailitys of this system, one should take this 
consideration into account. 
Since quantification of the reporter system involves microscopic work, we used the acquired 
pictures to examine other morphological parameters, like area. Strains expressing Ser-tRNAUGA and 
Figure 4.12 – Quantification of the mean fluorescence of evolved Leu mutants expressing Ser-tRNAGAG. 
The right picture is a representative photo of positive clones, showing the population heterogeneity. 
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Ser-tRNAGAG were bigger after evolution, a phenotype that was not seen in the evolved strain with 
the empty plasmid (figure 4.13). This may indicate that evolved strains developed aneuploidies. 
Studies haves shown that aneuploidy induces genomic instability and mutagenesis in yeast (117). 
On the other hand, aneuploidy has also been linked to phenotypic variation and growth advantage 
in some conditions, which raises the hypothesis that in adverse environments, aneuploidy can 
provide a mechanism for cells to frisk phenotypic variations and thus adapt (118).   
 
 
 
Beside the dubious results from the Arginine set, un-evolved and evolved mutants were also 
visualized under the microscope. Although none of the later parameters were quantified, the 
morphology of these cells highlight again the differences between the two sets, as can be seen in 
figure 4.14. Regarding the un-evolved forms, cells were not different from cells belonging to the 
Leucine set. Only a slight tendency to more elliptical and aggregated forms was seen in mutants 
with high expression of the mutant Ser-tRNACCU. After 200 generations, the later presented 
abnormal cells with bigger, elongated and lobulated forms that tend to aggregate. Interestingly, 
cells evolved with low expression of the mutant Ser-tRNACCU and later transformed with the 
reporter plasmid (note that the reporter backbone is a multi-copy vector) consistently show a 
flocculated phenotype. Together, this data show that these clones are under a higher stress than 
the Leucine ones and that the underlying mechanisms involved in each sets are different. Worthy 
of note, is the visual differences between cells expressing Ser-tRNAUGA and Ser-tRNACCU that 
Figure 4.13 – Area measurements from non-evolved and evolved Leu mutants. The panel at the right has 
representative pictures (at scale) from each group. 
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together with the reported differences in growth rate, lag phase duration and tRNA expression 
seems to indicate that they are not isogenic as sequencing data suggests. 
 
 
 
 
4.2.6 Discussion 
After evolution, the strong negative effects produced by high expression of mutant and 
endogenous tRNAs were minimized, showing that cells have undergone a process of adaptation. 
Figure 4.14 – Representative pictures of non-evolved and evolved Arg mutants. The upper row shows 
un-evolved strains with high expression of Ser-tRNAUGA (ΔtR+MC_UGA) and Ser-tRNACCU (ΔtR+MC_CCU); 
middle row shows evolved strains with high expression of Ser-tRNAUGA (EΔtR+MC_UGA) and strains 
evolved in the low copy version of Ser-tRNACCU (EΔtR+SC_CCU); the last row shows pictures from evolved 
strains with high expression of Ser-tRNACCU (EΔtR+MC_CCU) 
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Particularly, Leu mutants recovered significantly both in growth rate and in duration of lag phase. 
Also, the fluorescent reporter system constructed to monitor Ser misincorporation at CUC-Leu sites, 
showed that serine was indeed incorporated and possibly codon reassignment was achieved. These 
data shows that these strains adapted to mistranslation.  
Indeed, all the observations relative to Leu mutants expressing Ser-tRNAGAG at high level are 
consistent with the exciting idea of a possible codon reassignment. Through the evolution 
experiment, cells kept expressing the mutant tRNA and even showed an increase in its expression 
at the end of the experiment. Also, evolved strains were able to go through another complete round 
of evolution in rich media without losing the plasmid. We cannot assertively speculate the 
functional implication of the mutation C62U found in all Ser-tRNAGAG clones, but one must assume, 
since there was a recovery at the end, that during the course of evolution, if a preferential mutation 
accumulates, so it must be to better capacitate the cell to their genetic environment. Together 
these results indicate that the tRNA is being selected as beneficial and it is selectively transmitted 
to the offspring, even when no pressure to maintain the plasmid is kept. 
Also, after evolution, these cells apparently developed aneuploidies, which is indicative of 
genome instability. It has been purposed that codon ambiguities destabilize the proteome in a 
dynamic way producing fluctuating genome instabilities of relevance to evolution and adaptation. 
In fact, codon ambiguity and evolution induces major changes in genome structure and gene 
expression (58). The developed aneuploidy may possibly be due to this genetic dynamic, although 
we do not have enough information to make such a statement. Sequencing the whole genome of 
our recombinant strains would provide valuable data if the acquired tolerance to codon ambiguity 
is the result of the accumulation of compensatory mutations along the evolution cycles, like single 
nucleotide polymorphisms (SNPs), small insertions and deletions (indels), gene copy number 
variation (CNV), loss of heterozygosity (LOH) or karyotype alterations. 
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Chapter 5 
 
5. Discussion 
 
5.1 General discussion and main conclusions 
In recent years, remarkable efforts have been made to integrate unnatural amino acids with 
novel chemical properties into proteins (74). However, the main focus of these studies was 
production and characterization of novel proteins rather than codon reassignment. In this thesis, 
we tackled the later problem by generation of ambiguity at specific codons by an experimental 
strategy which involved deletion of single-copy tRNA genes followed by expression of non-cognate 
tRNAs that are able to compensate the decoding of the deleted tRNAs. Since the targeted codons 
are “orphan” and decoded inefficiently via wobble interactions by other iso-acceptor tRNAs (64, 85, 
87), our system is expected to be highly detrimental to the cell homeostasis but was viable and 
different lineages adapted differently to codon ambiguity during an experimental evolution 
procedure. This work provides a series of proof-of-principle experiments that confirm that our 
experimental approach is valid, since recombinant strains, even those with high level expression of 
misreading tRNAs, remained viable. 
Data from online codon usage databases (119) shows that in the S. cerevisiae nuclear genome, 
CUC-Leu and AGG-Arg codons have a usage frequency of 5.5‰ and 9.2‰ respectively, which 
illustrates its low usages (96). However CUC codons represents 17499 and AGGs represents 28483 
codons across the yeast ORFeome, so misincorporation of serine across all these sites is expected 
to cause major proteome disruption. Indeed the presented results in this work shows the harsh 
deleterious consequences induced by ambiguous decoding. Cells with high expression of Ser-tRNAs 
showed extended lag phases and their growth rates dropped around 50% (figures 3.4 and 3.5), in 
relation to WT and deletion controls, which is concordant with high synthesis of aberrant proteins 
and indicates also that ambiguous strains may have defects in cell cycle progression or metabolism.  
Indeed, bioinformatics codon content analysis suggests that cAMP related pathways may be 
compromised in our cells, as a series of key components of the PKA metabolic pathway have high 
frequency of these codons (figure 3.7). Since our mistranslating system has the potential to 
incorporate one of two amino acids at each one of these codons (Ser or Leu in ΔtL, and Ser or Arg 
in ΔtR), so translation of these genes will produce a group of statistically related proteins, and some 
of them will have deficient folding and function, as errors accumulate in their sequences. 
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Particularly, the gene that encodes the adenylate cyclase responsible for cAMP synthesis (CYR1) 
has 16 CUCs and 25 AGGs, so it is expected that our strains have low intracellular cAMP 
concentrations, which will lead to low cAMP-dependent kinases activity, like PKA. Since inactivation 
of adenylate cyclase, PKA or Cdc25 results in similar phenotypes of permanent arrest at G0, unless 
cAMP is provided to the cells (120, 121), one can assume that some of the statistical proteins 
produced by our mutants are indeed functional as cells are viable and, although the observed delay 
in growth, they are able to surpass the cell cycle arrest.  
One of the most intriguing and unexpected phenotypes was observed upon major deregulations 
of the endogenous tRNA pool by high expression of the seryl tRNAUGA. Elevated tRNA levels are 
reported in pathologies like ovarian, breast and cervical cancers, due to aberrant RNA polymerase 
III expression (122-124). Interestingly, it has been reported that overexpression of Met-tRNAi in 
non-tumorigenic human breast epithelial cell lines induced increased levels of the other tRNAs, 
which resulted in increased metabolic activity and proliferation (125). However, information about 
the consequences of increased tRNA concentration are scarce. In E. coli, overexpression of Leu-
tRNACAG led to very slow growth and inhibition of protein synthesis. The authors showed that 
elevated levels of tRNA led to titration of LeuRS as only 40% of tRNAs were aminoacylated, and of 
modifying enzymes as part of the tRNA were hypomodified. Also, they reported reduced rate of 
protein synthesis with negligible misreading and that particular proteins were over-produced (126). 
Another interesting relation arose from the suppression of several amber and ochre codons upon 
overexpression of Gln-tRNA with CUG (127) and UUG (128) anticodons, respectively. On the other 
hand, tRNA selection by the ribosome is affected by tRNA concentration and more abundant tRNAs 
are preferentially selected as they are more rapidly translated (3). So one can hypothesize that due 
to increased Ser-tRNAUGA expression, decoding of Ser-UCA codons is faster, which will produce an 
imbalance in translational speed, and increases in translational elongation speed are known to 
produce a trade-off of decreased accuracy (129, 130). Since UCA codons are rather frequent in the 
genome, with a usage frequency of 18.7‰ in yeast, this potential effect is extended to a large set 
of genes (ANACONDA codon content analysis revealed that only 8.6% of yeast genes do not have 
this codon) and may function as “disruption hotspots” of translation speed and accuracy. 
Importantly, one must always have in mind that our strains already have disturbed translation, due 
to the loss of the single cognate tRNA capable of decoding CUC or AGG codons. We cannot make 
an assertive guess based on the data presented, but we can speculate that any of the disturbances 
above have the potential to further aggravate fidelity of translation by further destabilizations of 
the endogenous tRNA pool.  Our results, together with these observations shows how little we 
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know about how cells respond to perturbations in cellular tRNA levels and how they regulate the 
individual expression of each tRNA. 
The harmful consequences of erroneous translation have been widely reported, however 
information about long-term evolutionary responses to mistranslation is not known. We explored 
the hypothesis that forced evolution, in combination with ambiguous decoding, has the potential 
to release codons from their frozen state by evolving ambiguous strains throughout 200 
generations. The Leucine mutants mostly affected by seryl tRNA expression, namely those with high 
expression of Ser-tRNAs (MC), recovered significantly in growth rate and in the time need to enter 
exponential growth (figure 4.2 and 4.3), which indicates that our mutants adapted to 
mistranslation. Given the fact that C. albicans naturally decodes the ambiguous CUG-Leu codon as 
Ser in the cytoplasm, one can hypothesize that these type of ambiguous decoding is tolerable, 
beside the inherent negative of a proteome-wide substitution.  
Interestingly, all Leucine mutants (un-evolved and evolved) with high expression of the 
misreading Ser-tRNAGAG presented a single mutation in the TψC arm, where C62 changed to U62. 
Also, the observed phenotypes are not due to tRNA degradation, as northern blot analysis revealed 
that its expression even increases throughout evolution. Although the functional consequences of 
the observed mutation remains elusive, on must assume that they must be functional in some way, 
as it is present in every single clone from this group.  
Consistent with our expectation, the reporter system built to monitor Ser misincorporation at 
Leu-CUC sites, revealed a complete loss of function in strains highly expressing Ser-tRNAGAG, which 
indicates that high rates of Ser is being misincorporated at Leu-CUC codons. However, results taken 
from the fluorescent reporter experiment must be taken carefully, as they show signal 
heterogeneity and the results are solely indicative. Together, these results suggest that possible 
codon reassignment may have been achieved in these cells. 
 
 
5.2 Future work 
Yeast cells were able to tolerate high level misincorporation of Ser at rare and “orphan” Leu-
CUC codons, which have lost its cognate tRNA, with high negative costs to cellular fitness. However, 
throughout evolution, cells were able to adapt to their mistranslating environment and recover 
25% of their growth rate, achieving fitness levels similar to the ones seen in the deletion strain. The 
results obtained in this work raises a series of intriguing questions that are worth further 
investigation. 
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Although ambiguous decoding is highly detrimental due to synthesis of aberrant proteins, it has 
been shown to provide important selective advantages in S. cerevisiae under stress conditions, 
otherwise lethal (34). Candida albicans decodes naturally the CUG-Leu codons as Ser in vivo, and 
accommodates a basal level of Leu-mistranslation of ~3% at optimal conditions (70). By increasing 
its level of mistranslation novel phenotypes arise, which implies that codon ambiguity has the 
potential to expand the proteome (58, 70). So it would be very interesting to do a phenotypic screen 
over a large set of conditions, in order to clarify whether the ambiguous strains would produce 
adaptive phenotypic alterations.  
Since codon ambiguity and evolution induces major changes in genome structure and gene 
expression (58), it would be interesting to perform whole-genome sequencing of our recombinant 
strains. This would provide insightful data to whether our ambiguous strains acquire tolerance to 
codon ambiguity through the accumulation of compensatory mutations along the evolution cycles, 
as fitness parameters seem to suggest. 
In order to get a complementary insight on the mechanism of tolerance to codon ambiguity and 
reassignment, it would be of interest to perform a transcriptome analysis. Since codon ambiguities 
disrupt protein structure and activate the stress response (10) we expect high gene deregulation at 
the start of each evolution cycle and gradual attenuation along the evolution, as adaptive mutations 
accumulate in the genome.  
The main frailty in this work is the reporter system used to assess ambiguity level that, as already 
discussed, is far from optimal. So an important aspect to be improved is the quantification of Ser 
misincorporation at the targeted codons, as for example by mass-spectrometry techniques. One 
possible approach is by using an assay previously developed in the host laboratory, which is based 
on a mass-spectrometry reporter construct that consists in a cassette with the codon of interest 
(CUC and AGG) inserted in the CaPGK gene. The codon-cassette is flanked by two thrombin cleavage 
sites that facilitate the purification of the short reporter peptide encoded by the cassette (131). 
Another important aspect is to rethink the overall strategy for the Arginine set. As our results 
shows, the underlying genetic background of the ΔtR(CCU)J is complex and more sensitive to 
deregulations. To abrogate the impact of the insertion of the empty vector in these strains, we 
should rethink the selective marker used in the plasmid, since it appears that even one AGG codon 
in the URA3 has the potential to disrupt the enzyme encoded. However the auxotrophy of theses 
strains presents a limited set of alternatives and so this aspect must be carefully planned.  
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Annexs 
 
Drop-out mix: 
 0.25g Adenine 
 1 g Alanine 
 1 g Arginine 
 1 g Asparagine 
 1 g Aspartate 
 1 g Cysteine 
 1 g Glycine 
 1 g Histidine 
 1 g Inositol 
 1 g Isoleucine 
 1 g Glutamate 
 1 g Glutamine 
 1 g Lysine 
 1 g Leucine 
 1 g Methionine 
 1 g Phenylalanine 
 1 g Proline 
1 g Serine 
1 g Threonine 
1 g Tryptophan 
1 g Tyrosine 
1 g Uracil 
1 g Valine 
 
 
5-FOA Plates (1 L): 
 20 g Agar 
 500 ml dH2O 
  Autoclaved separately 
 6.7 g Bacto-yeast Nitrogen Base 
 2 g Drop-out –Ura 
 20 g Glucose 
 50 mg Uracil (50 µg/ml) 
 1 g 5-FOA 
 500 ml dH2O 
  Filtered by 0.02 µm filters and added to the agar when cooled to ~ 55ºC 
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Plasmid Maps 
 
Figure 2.1 – Maps of the constructed plasmids pUA715 and pUA716 used as backbone for expression 
of mutant tRNAs, with insertion of the C. albicans tRNASerUGA gene between SalI and BamHI in the multi-
copy vector pRS426 (A), and between SpeI and SalI in the single-copy vector pRS316 (B).  
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Figure 2.2 – Map of the constructed reporters pUA721 and pUA733. (A) Backbone for control plasmids, 
only with GFP inserted between KpnI and XhoI (positions of interest were posteriorly mutated).(B) 
Backbone for the reporter construction, with insertion of the mutagenized tRNASerGAG gene between the 
restriction sites SalI and BamHI, and the yE-GFP gene between KpnI and XhoI (positions of interest were 
posteriorly mutated).  
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Table 3.3 – Complete list of PKA related genes and CUC and AGG codon frequency 
 
Gene Description 
No. CUC 
codons 
No. AGG 
codons 
IRA2 GTPase-activating protein 22 31 
IRA1 GTPase-activating protein 19 30 
CYR1 Adenylate cyclase 16 25 
RIM15 Protein kinase involved in cell proliferation 15 21 
TOR1 Phosphatidylinositol kinase-related protein kinase 13 23 
CCC2 Cu
2+
-transporting P-type ATPase 10 6 
GEX2 Proton:glutathione antiporter 10 4 
GPR1 Plasma membrane G-protein coupled receptor 10 5 
TOR2 Phosphatidylinositol kinase-related protein kinase 10 37 
GEX1 Proton:glutathione antiporter 9 4 
CDC25 Ras-guanine exchange factor 6 20 
ROM2 GDP/GTP exchange factor for Rho proteins 6 16 
BCY1 cAMP-dependent protein kinase regulatory subunit 5 5 
GPB1 Multistep regulator of cAMP-PKA signaling 5 13 
GPB2 Multistep regulator of cAMP-PKA signaling 5 7 
MSN2 Transcriptional activator, activated in stress conditions 5 6 
ATG13 Regulatory subunit of the Atg1p signaling complex 4 5 
GPA2 
Nucleotide binding alpha subunit of the heterotrimeric  
G protein Gpr1p 
4 8 
KSP1 Serine/threonine protein kinase 4 13 
PHO80 Cyclin, interacts with cyclin-dependent kinase Pho85p 4 1 
SCH9 AGC (PKA, PKC, PKG) family protein kinase 4 3 
UBP3 
Ubiquitin-specific protease involved in transport and osmotic 
response 
4 4 
YAK1 Serine-threonine protein kinase 4 11 
ATG1 Protein serine/threonine kinase 3 11 
PDE2 3',5'-cyclic-nucleotide phosphodiesterase 3 3 
PHO85 cyclin-dependent serine/threonine-protein kinase 3 2 
WHI3 RNA binding protein that sequesters CLN3 mRNA 3 4 
YPL260W Putative substrate of cAMP-dependent protein kinase 3 5 
COM2 Transcription factor that binds IME1 Upstream Activation Signal 2 9 
FLO11 GPI-anchored cell surface glycoprotein (flocculin) 2 0 
73 
 
LYS1 saccharopine dehydrogenase (NAD
+
, L-lysine-forming) 2 1 
PAT1 Deadenylation-dependent mRNA-decapping factor 2 5 
PDE1 3',5'-cyclic-nucleotide phosphodiesterase 2 3 
SPI1 GPI-anchored cell wall protein 2 0 
YPK3 AGC kinase 2 5 
GAS1 1,3-beta-glucanosyl transferase 1 0 
MYO2 Type V myosin motor involved in actin-based transport 1 12 
RAS1 
GTPase involved in G-protein signaling in adenylate cyclase 
activation 
1 2 
SLT2 Mitogen-activated serine/threonine-protein kinase 1 6 
SNF1 AMP-activated serine/threonine-protein kinase catalytic subunit 1 5 
SOK2 
Nuclear protein that negatively regulates pseudohyphal 
differentiation 
1 5 
TOM22 Component of the TOM (translocase of outer membrane) complex 1 0 
TPK2 Ras family GTPase 1 5 
CDC19 Pyruvate kinase 0 0 
CYC1 Cytochrome-c isoform 1 0 0 
HSP12 Lipid-binding protein 0 0 
PHO84 High-affinity inorganic phosphate (Pi) transporter 0 0 
RAS2 Ras family GTPase 0 5 
TOM40 Component of the TOM (translocase of outer membrane) complex 0 0 
TPK1 cAMP-dependent protein kinase catalytic subunit Tpk1 0 5 
TPK3 cAMP-dependent protein kinase catalytic subunit Tpk3 0 3 
WHI2 Protein required for full activation of the general stress response 0 4 
 
 
 
